{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":84,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":84,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"9068ed2785af","filters":{"venue":"npj Breast Cancer"}},"results":[{"id":"W2947470150","doi":"10.1038/s41523-019-0111-0","title":"SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Berlin Institute of Health; Deutsche Forschungsgemeinschaft; Breast Cancer Research Foundation","keywords":"Breast cancer; Metastatic breast cancer; Medicine; Internal medicine; Oncology; Cancer; Targeted therapy; Endocrine system; Hormone; Bioinformatics; Cancer research; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03199847053610999,"gpt":0.3266311783684151,"spread":0.2946327078323051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003330502,0.0006902224,0.001178444,0.0002346644,0.000164559,0.00005585355,0.0002235414,0.0001170738,0.002315165],"category_scores_gemma":[0.00002973372,0.0005862804,0.000442621,0.0004129428,0.0001202258,0.0003472501,0.00007883855,0.0002594754,0.00004742214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001054284,"about_ca_system_score_gemma":0.0008138126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001060216,"about_ca_topic_score_gemma":0.0004112454,"domain_scores_codex":[0.9964226,0.0000752547,0.0005678834,0.001142463,0.0005840157,0.001207753],"domain_scores_gemma":[0.9971489,0.0002722469,0.000269538,0.0008337447,0.0009294971,0.0005461115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0440372,0.00110273,0.0604785,0.001650555,0.003312977,0.00005403517,0.0009740553,0.008526247,0.2300238,0.0001708094,0.00830463,0.6413645],"study_design_scores_gemma":[0.06798769,0.002602294,0.6036634,0.002382181,0.00177402,0.005358204,0.0005842158,0.01002692,0.05992063,0.0006537287,0.241713,0.003333699],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8555619,0.004757583,0.04162699,0.03539854,0.003445121,0.01542367,0.04290551,0.0006684224,0.0002122586],"genre_scores_gemma":[0.9636698,0.0004170219,0.01403286,0.008036634,0.002854286,0.007095453,0.0002597266,0.0003655188,0.003268699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6380308,"threshold_uncertainty_score":0.9996589,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3214960410","doi":"10.1038/s41523-021-00346-1","title":"The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Université de Montréal; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Ontario Institute for Cancer Research","funders":"Medical Research Council; National Cancer Institute; Cancer Research UK; National Institutes of Health; National Breast Cancer Foundation; National Center for Advancing Translational Sciences; Royal Australasian College of Physicians; National Health and Medical Research Council; Breast Cancer Research Foundation","keywords":"Oncology; Immunotherapy; Breast cancer; Medicine; Tumor-infiltrating lymphocytes; Biomarker; Internal medicine; Immune checkpoint; Cancer; Clinical Oncology; Triple-negative breast cancer; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0420120292087145,"gpt":0.3629201689834325,"spread":0.320908139774718,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009708207,0.0004843424,0.001684066,0.0001312098,0.000139881,0.00007568312,0.0007596745,0.0004309878,0.002490636],"category_scores_gemma":[0.00003612266,0.0002715771,0.0008686139,0.0007239135,0.0004130137,0.00006848116,0.0002464785,0.0006672106,0.000005406652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001992537,"about_ca_system_score_gemma":0.002857143,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01999597,"about_ca_topic_score_gemma":0.005664071,"domain_scores_codex":[0.9965618,0.0002817235,0.00140598,0.0006670422,0.000628764,0.0004547166],"domain_scores_gemma":[0.9969824,0.0005915464,0.00117183,0.0009446556,0.0002342412,0.00007532675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009349067,0.0001265148,0.004378488,0.0004309702,0.002480616,0.0002579064,0.000111224,2.385763e-7,0.0001098503,0.000009550591,0.01018052,0.9809792],"study_design_scores_gemma":[0.001269671,0.00001557059,0.02462304,0.02415375,0.0007678755,0.003475751,0.0001428819,0.000006041384,0.000003549756,0.000006597814,0.9452745,0.0002607554],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002471339,0.9855031,0.000003562335,0.007065105,0.003688613,0.0008395672,0.001153438,0.00002458328,0.001474946],"genre_scores_gemma":[0.001009672,0.9949391,0.00002575447,0.0006028031,0.001381005,0.000868212,0.0004043365,0.00008106471,0.0006879854],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9807184,"threshold_uncertainty_score":0.9999737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2982449517","doi":"10.1038/s41523-019-0133-7","title":"If we build it they will come: targeting the immune response to breast cancer","year":2019,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Tumor microenvironment; Immune system; Immunotherapy; Immunology; Antigen presentation; Breast cancer; Cancer research; Medicine; Antigen; Cancer immunotherapy; Cancer; Biology; T cell; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02592234745956359,"gpt":0.3392283886206269,"spread":0.3133060411610633,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001506009,0.001113383,0.002838157,0.0003399605,0.0003201643,0.0001301931,0.0009976977,0.0005951751,0.006425629],"category_scores_gemma":[0.00004882986,0.0006677328,0.00139723,0.0009428874,0.0002183715,0.0001730868,0.00028827,0.001239099,0.000323981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002143221,"about_ca_system_score_gemma":0.002961194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006093196,"about_ca_topic_score_gemma":0.0002407547,"domain_scores_codex":[0.9950051,0.0005892445,0.001317807,0.001091751,0.0009131516,0.001083002],"domain_scores_gemma":[0.9964468,0.0004587909,0.0007775944,0.001628744,0.0003642664,0.0003237601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008271825,0.00009839972,0.0001583511,0.006647615,0.001685449,0.00003234598,0.0004308575,0.000006638724,0.0002373214,0.000008852787,0.03118589,0.9512364],"study_design_scores_gemma":[0.001642339,0.0001013397,0.002209356,0.0407372,0.001861839,0.001075122,0.0001243729,0.000004616612,0.000008780255,0.000003194359,0.9514269,0.0008048976],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001168452,0.9513222,0.000007974931,0.03901526,0.002617456,0.002912101,0.003393251,0.0001230022,0.0004919246],"genre_scores_gemma":[0.0008363266,0.9818176,0.00003323191,0.003401608,0.002528298,0.001345348,0.00009705704,0.0002973837,0.00964315],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9504316,"threshold_uncertainty_score":0.9995774,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016939709","doi":"10.1038/s41523-020-0156-0","title":"Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; Spinal Cord Injury BC; National Circus School; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Center for Research Resources; Daiichi Sankyo Europe; National Cancer Institute; Medical Research Council; Stand Up To Cancer; National Institutes of Health; Rosetrees Trust; CRUK Lung Cancer Centre of Excellence; National Institute for Health and Care Research; University College London; Wellcome Trust; Cancer Research UK; Wallace H. Coulter Foundation; Myriad Genetics; Francis Crick Institute; Georgia Clinical and Translational Science Alliance; Susan G. Komen; Prostate Cancer Foundation; AstraZeneca; U.S. Department of Defense; Eli Lilly and Company; Case Western Reserve University; National Breast Cancer Foundation; U.S. Department of Veterans Affairs; Breast Cancer Alliance; Pfizer; Amgen; European Commission; DOD Peer Reviewed Cancer Research Program; Breast Cancer Research Foundation","keywords":"Breast cancer; Cancer; Medicine; Stromal cell; Breast tumor; Pathology; Stromal tumor; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01998069372488021,"gpt":0.3012786581673034,"spread":0.2812979644424232,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002004894,0.0003163875,0.00054736,0.0001594769,0.00006439595,0.00008641547,0.0001706511,0.0001176921,0.002001315],"category_scores_gemma":[0.00002032522,0.0002902933,0.0001252294,0.0007898223,0.0001143947,0.0003775294,0.0000513493,0.0003779042,0.00001094436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00116609,"about_ca_system_score_gemma":0.001301761,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01464209,"about_ca_topic_score_gemma":0.001724028,"domain_scores_codex":[0.9978503,0.00007005092,0.0005677193,0.0005329175,0.0003919833,0.0005870298],"domain_scores_gemma":[0.9992552,0.00005330696,0.000177571,0.0002084581,0.0000924913,0.0002129333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002825296,0.0001301487,0.8261437,0.000235993,0.00008862274,0.0001864586,0.00076593,0.000199043,0.08256759,0.000009245428,0.0006150115,0.08623292],"study_design_scores_gemma":[0.006242288,0.00005682341,0.9856553,0.001438358,0.00004480347,0.0003442893,0.0006089952,0.002290317,0.002062231,0.000005214559,0.0009021535,0.000349236],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805284,0.00259635,0.00001513727,0.01480058,0.0003033063,0.0003820315,0.0002388067,0.00008463246,0.001050779],"genre_scores_gemma":[0.9916757,0.0003532864,0.0001916797,0.006733452,0.0007862942,0.000145595,0.00001420473,0.0000565241,0.00004323743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1595116,"threshold_uncertainty_score":0.9999549,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3025630280","doi":"10.1038/s41523-020-0154-2","title":"Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group","year":2020,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Université Laval; Translational Research in Oncology; University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"National Center for Research Resources; Genentech; National Institute for Health and Care Research; Cancer Research UK; Puma Biotechnology; Georgia Clinical and Translational Science Alliance; Susan G. Komen; Daiichi Sankyo Europe; National Cancer Institute; Case Western Reserve University; G1 Therapeutics; Celgene; Eli Lilly and Company; U.S. Department of Defense; DOD Peer Reviewed Cancer Research Program; Leidos; Breast Cancer Research Foundation; Sanofi; AstraZeneca; U.S. Department of Veterans Affairs; National Institutes of Health; U.S. Department of Health and Human Services; Breast Cancer Alliance; Wallace H. Coulter Foundation; Pfizer; Amgen","keywords":"Biomarker; Oncology; Internal medicine; Medicine; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03036765664404596,"gpt":0.3470418753804594,"spread":0.3166742187364135,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000202528,0.0002895434,0.0006248724,0.00003651683,0.00007185921,0.00005183894,0.0004705758,0.0001777683,0.0001368859],"category_scores_gemma":[0.00007719479,0.0002216996,0.0003210518,0.000100294,0.00009447706,0.000002573076,0.0002748351,0.000177554,0.000002999222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004189092,"about_ca_system_score_gemma":0.001931887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004367102,"about_ca_topic_score_gemma":0.0001161751,"domain_scores_codex":[0.9983138,0.00008761341,0.0006601138,0.0005025897,0.0002661055,0.0001698217],"domain_scores_gemma":[0.9983647,0.0002939655,0.0008367001,0.0003262092,0.0001213797,0.00005699469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006957224,0.00008124585,0.00178713,0.0002011857,0.0009774945,0.00006120806,0.00001420844,0.000274689,0.0002977205,0.0001538049,0.004232864,0.9918489],"study_design_scores_gemma":[0.000369652,0.00005809403,0.002708773,0.001531779,0.0002200135,0.0002597198,0.00001371812,0.0002035849,0.00001968951,0.00003053253,0.9943526,0.0002317924],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004805842,0.9925802,0.0004435616,0.0005343265,0.00170096,0.0004069585,0.00193694,0.00001004573,0.001906472],"genre_scores_gemma":[0.007913376,0.9844298,0.001328007,0.0009221614,0.001937432,0.0002160934,0.003175576,0.00005838278,0.00001921094],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9916171,"threshold_uncertainty_score":0.9040648,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2407306171","doi":"10.1038/npjbcancer.2016.14","title":"Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; University of Alberta; Ontario Institute for Cancer Research; Juravinski Hospital; McMaster University; Health Sciences Centre; Mount Sinai Hospital; University of British Columbia","funders":"Cure Brain Cancer Foundation; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Government of Ontario; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Intraclass correlation; External quality assessment; Reproducibility; Medicine; Nuclear proliferation; Protocol (science); Breast cancer; Core biopsy; Confidence interval; Biomarker; Multicenter study; Nuclear medicine; Pathology; Statistics; Internal medicine; Cancer; Mathematics; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.02472987160192667,"gpt":0.3991916576170507,"spread":0.374461786015124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009193323,0.0001004717,0.00014725,0.00003843764,0.00002545707,0.000007749371,0.00009044746,0.00005108973,0.00009090242],"category_scores_gemma":[0.00004150948,0.00007193358,0.0000601827,0.00005359103,0.00007125581,0.00002171536,0.00003232604,0.00001317826,3.698063e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000787903,"about_ca_system_score_gemma":0.0001357285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003655649,"about_ca_topic_score_gemma":0.00003645281,"domain_scores_codex":[0.9992582,0.00002579293,0.0002296202,0.0002208602,0.0001562232,0.0001093173],"domain_scores_gemma":[0.9990297,0.00001308364,0.0001706238,0.0001637241,0.0005854141,0.00003746012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02420175,0.001233594,0.1144694,0.0001751806,0.0008003691,7.876005e-7,0.000218913,0.0001016927,0.7596403,0.0002120227,0.0006523672,0.09829367],"study_design_scores_gemma":[0.01905287,0.000343263,0.02142685,0.0001699389,0.00007279732,0.00000353602,0.00005675433,0.0001974395,0.952561,0.0000290282,0.005945812,0.0001406879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9638367,0.00001248383,0.007445053,0.001077813,0.0002408026,0.02335251,0.00380251,0.00001427508,0.0002178987],"genre_scores_gemma":[0.9639215,0.000006220267,0.0009167662,0.00002262147,0.0002640237,0.03474874,0.00006263224,0.00001472728,0.00004270731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1929208,"threshold_uncertainty_score":0.2933366,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623464423","doi":"10.1038/s41523-017-0024-8","title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Oxnard Foundation; Pennsylvania Department of Health; Stop Cancer; Avon Foundation for Women; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Breast cancer; CHEK2; PALB2; Odds ratio; Oncology; Medicine; Germline mutation; Cancer; Genetics; Internal medicine; Mutation; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.008631985747489999,"gpt":0.2878752612757638,"spread":0.2792432755282738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006429072,0.0003637663,0.0003896523,0.00006285955,0.0006237101,0.0001060526,0.0009013525,0.0003083242,0.0003141291],"category_scores_gemma":[0.00006927172,0.0002998531,0.0001934007,0.0001878417,0.0004978887,0.00003177705,0.0003730261,0.0002586104,0.00001021184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007131858,"about_ca_system_score_gemma":0.001397531,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02735317,"about_ca_topic_score_gemma":0.07094917,"domain_scores_codex":[0.997332,0.0002013078,0.0005548897,0.0008527444,0.0003791628,0.000679917],"domain_scores_gemma":[0.997014,0.00002902323,0.0005256976,0.001408173,0.0008282537,0.000194848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001309859,0.0001046171,0.621515,0.00002380943,0.0002067298,0.000002583116,0.00009005844,0.001460224,0.2197587,0.00003300072,0.001750021,0.1537454],"study_design_scores_gemma":[0.001543889,0.00003550825,0.9795063,0.00009859867,0.0001012515,0.00005366874,0.00006989871,0.0002137052,0.0148208,0.00008239673,0.003101027,0.0003729468],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749753,0.003555568,0.0001822865,0.006370779,0.001665755,0.0006904349,0.01243262,0.00001709168,0.0001101008],"genre_scores_gemma":[0.991022,0.006252075,0.00006114549,0.0002823593,0.001363036,0.0007215585,0.00004963538,0.00005314282,0.0001950643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3579913,"threshold_uncertainty_score":0.9999453,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2753529942","doi":"10.1038/s41523-017-0040-8","title":"Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design","year":2017,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Victoria; University of British Columbia","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; National Institutes of Health; ECOG-ACRIN Cancer Research Group; Harvard University; American College of Radiology Imaging Network; Breast Cancer Research Foundation; Susan G. Komen for the Cure","keywords":"Medicine; Weight loss; Breast cancer; Overweight; Cancer; Randomized controlled trial; Body mass index; Weight change; Internal medicine; Obesity; Physical therapy; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.08614657863996368,"gpt":0.4208260353502067,"spread":0.334679456710243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00140459,0.0008675226,0.006532453,0.0001987278,0.0001386439,0.00004402615,0.0003517568,0.0002477595,0.000572344],"category_scores_gemma":[0.00003283273,0.0004358552,0.0004808826,0.0003155402,0.0005549417,0.0001244151,0.00007254937,0.000399085,0.000001505003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001407946,"about_ca_system_score_gemma":0.002873684,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02292074,"about_ca_topic_score_gemma":0.001268973,"domain_scores_codex":[0.9953501,0.0007808915,0.001517267,0.0008483061,0.0008946608,0.0006087962],"domain_scores_gemma":[0.9958502,0.0004603042,0.0020951,0.001040889,0.0003064209,0.0002471024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4064659,0.001198875,0.002499723,0.0009889659,0.001654095,0.00002421684,0.00188513,0.000004020593,0.000002251757,0.000001884486,0.000005088703,0.5852699],"study_design_scores_gemma":[0.9438559,0.005644581,0.004725795,0.01826358,0.008412152,0.0001721839,0.0002534743,0.00009206439,0.000007382556,0.00001697193,0.01794199,0.0006138746],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1634451,0.8240455,0.00000554548,0.00005491316,0.0002707916,0.01097352,0.00112393,0.00001677108,0.00006397549],"genre_scores_gemma":[0.1345726,0.8571131,0.0000250187,0.00001002981,0.0006581206,0.007228262,0.00001331712,0.00009983675,0.0002796571],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.584656,"threshold_uncertainty_score":0.9998093,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399806930","doi":"10.1038/s41523-024-00653-3","title":"Use of ctDNA in early breast cancer: analytical validity and clinical potential","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"Svenska Sällskapet för Medicinsk Forskning","keywords":"Breast cancer; Circulating tumor DNA; Medicine; Oncology; Internal medicine; Clinical trial; Cancer; Minimal residual disease; Clinical Practice; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02761222248979277,"gpt":0.3205653539150176,"spread":0.2929531314252248,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001684001,0.0001567805,0.0002456779,0.00005844492,0.0000244267,0.00006657898,0.0001079052,0.0001932441,0.0001084348],"category_scores_gemma":[0.00002632877,0.000148744,0.0001337546,0.0001234229,0.0001819692,0.00001058753,0.0001375425,0.0001714235,0.000002983728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005404867,"about_ca_system_score_gemma":0.0003459075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004561188,"about_ca_topic_score_gemma":0.001403086,"domain_scores_codex":[0.9987662,0.00004864091,0.0003507415,0.0004543273,0.0001327809,0.0002473207],"domain_scores_gemma":[0.9994349,0.00004567356,0.00005435096,0.0002323561,0.00009354126,0.0001391856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007130404,0.0001957987,0.8986167,0.0001201513,0.000238362,0.00005321508,0.00004145279,0.000412798,0.0116936,0.0002566436,0.006542327,0.08111592],"study_design_scores_gemma":[0.0005873892,0.0001064991,0.9853953,0.0001233828,0.0001342277,0.00008906113,0.000008495196,0.002790393,0.001010709,0.00005974043,0.009451201,0.0002435842],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942219,0.001814281,0.0001198959,0.00111439,0.0006624631,0.0001182779,0.001880917,0.000009275371,0.00005861922],"genre_scores_gemma":[0.9922293,0.006377064,0.00006547615,0.0002184732,0.0009035588,0.00001966706,0.00002846238,0.00002686883,0.0001311508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08677862,"threshold_uncertainty_score":0.6895182,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2979775428","doi":"10.1038/s41523-019-0130-x","title":"Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer","year":2019,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastatic breast cancer; Blockade; Breast cancer; Oncology; Cancer; Chemotherapy; PD-L1; Internal medicine; Antibody; Clinical Practice; Radiation therapy; Immunotherapy; Immunology; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.1072204224332624,"gpt":0.3605841377611553,"spread":0.253363715327893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005968225,0.001047779,0.003118123,0.0006392491,0.00009829521,0.00009612313,0.0004837482,0.0004634474,0.003428049],"category_scores_gemma":[0.000008465719,0.0008419104,0.0009463478,0.001037446,0.0002548035,0.0002411103,0.0001187979,0.001110388,0.00008623681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002302934,"about_ca_system_score_gemma":0.001935007,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009157009,"about_ca_topic_score_gemma":0.001621671,"domain_scores_codex":[0.9953948,0.0003439328,0.001236086,0.001182242,0.000930522,0.0009124724],"domain_scores_gemma":[0.9977137,0.0001359753,0.0007852722,0.0009652404,0.0001683734,0.0002314701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009199039,0.0005641548,0.002572788,0.01821264,0.002115454,0.00003127754,0.000176556,0.000004131736,0.00001867702,0.00003927794,0.001809327,0.9735358],"study_design_scores_gemma":[0.0099992,0.0001500028,0.03609817,0.04710056,0.007296721,0.001398382,0.0001221175,0.00007913535,0.00002460754,0.00003215488,0.8959525,0.001746453],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007775425,0.9834521,0.000009044062,0.007435637,0.001175337,0.00301416,0.002686508,0.00009668737,0.001353025],"genre_scores_gemma":[0.003895485,0.9873831,0.0001287594,0.001620853,0.001037184,0.001994448,0.0007080401,0.0002648534,0.00296731],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9717894,"threshold_uncertainty_score":0.9994032,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3207569082","doi":"10.1038/s41523-021-00345-2","title":"Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"BC Cancer Agency; Cancer Research UK","keywords":"Subtyping; Breast cancer; Stromal cell; Cancer research; Oncology; Medicine; Lymphocytic infiltration; Androgen receptor; Estrogen receptor; Internal medicine; Pathology; Biology; Cancer; Prostate cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01155565826883234,"gpt":0.2640670857993745,"spread":0.2525114275305422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001696271,0.0007417178,0.000727509,0.0001099846,0.0004735432,0.00008177418,0.0003260237,0.0003320276,0.0004205656],"category_scores_gemma":[0.00001736087,0.0006726157,0.0003876276,0.0003288062,0.0002039733,0.00001480119,0.0001781663,0.0002184723,0.00001410956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008603662,"about_ca_system_score_gemma":0.00164834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002888337,"about_ca_topic_score_gemma":0.001471716,"domain_scores_codex":[0.9963729,0.0001561419,0.000540967,0.001472679,0.0004732477,0.0009840708],"domain_scores_gemma":[0.997421,0.00007347947,0.0003592838,0.0008749572,0.0009521014,0.0003192297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01529561,0.001188095,0.2979874,0.002038607,0.002186181,0.0002463362,0.0003359309,0.0119526,0.5889167,0.0001280587,0.02606852,0.0536559],"study_design_scores_gemma":[0.01187374,0.0001485163,0.4884902,0.004480931,0.0008642608,0.00267983,0.000872267,0.001631939,0.4805906,0.00001644401,0.006024001,0.002327324],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8936248,0.01826994,0.001098555,0.01981805,0.004493015,0.002217334,0.05906659,0.0003941045,0.001017582],"genre_scores_gemma":[0.9921054,0.0005022789,0.0004378015,0.001282113,0.002335575,0.002323174,0.000379703,0.0001788597,0.0004551412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1905028,"threshold_uncertainty_score":0.9995725,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3186178212","doi":"10.1038/s41523-021-00305-w","title":"IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Medical Research Council; Weston Park Cancer Charity; Trent University; British Heart Foundation; Nottingham Trent University","keywords":"Medicine; Breast cancer; Bone metastasis; Metastasis; Immune system; Cancer research; Cytokine; Anakinra; Cancer; Oncology; Internal medicine; Immunology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.0227616118986436,"gpt":0.3174416729130047,"spread":0.2946800610143611,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002645075,0.0002138592,0.0004679416,0.0003383096,0.00009177801,0.0000896009,0.00005120624,0.00006704882,0.0003642],"category_scores_gemma":[0.00005309976,0.0001963133,0.00007369651,0.0004301535,0.00006506052,0.0003052038,0.00006739746,0.0003126667,0.000002776548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006208838,"about_ca_system_score_gemma":0.0004925045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003138014,"about_ca_topic_score_gemma":0.001130599,"domain_scores_codex":[0.9984709,0.0001221883,0.0004223116,0.0004256736,0.0002467838,0.0003121129],"domain_scores_gemma":[0.999225,0.0001131078,0.0001126118,0.0001998308,0.0002162322,0.0001332395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0009548841,0.0003726215,0.4419053,0.0001447145,0.00005735119,0.000150658,0.001295703,0.00004010685,0.4767613,0.00005690324,0.0001989216,0.0780616],"study_design_scores_gemma":[0.002523404,0.00004908415,0.9785952,0.001127424,0.00007935439,0.0004234963,0.0007807217,0.0002268424,0.015215,0.00003247725,0.0007240041,0.0002229768],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742385,0.002210573,0.0000491742,0.02197635,0.0003828148,0.0002848696,0.0006106391,0.00003741319,0.0002097267],"genre_scores_gemma":[0.9967729,0.0002748379,0.0003221619,0.001908154,0.0001721588,0.0001390255,0.00003424783,0.00003827041,0.0003381805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5366899,"threshold_uncertainty_score":0.8005424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3197447043","doi":"10.1038/s41523-021-00325-6","title":"Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Region Midtjylland; Novo Nordisk Fonden; Steno Diabetes Center Aarhus; Aarhus Universitet","keywords":"Triple-negative breast cancer; Meta-analysis; Overweight; Medicine; Breast cancer; Oncology; Cancer; Triple negative; Internal medicine; Obesity","retraction":null,"screen_n_in":null,"score":{"opus":0.05144835486678905,"gpt":0.3636694195380953,"spread":0.3122210646713063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000396758,0.0009367559,0.01392954,0.000514789,0.00007148703,0.00008384954,0.0001614978,0.000328434,0.003342869],"category_scores_gemma":[0.00007515612,0.0005822948,0.002198769,0.002106131,0.000129817,0.0001710067,0.0001420177,0.0006077202,0.00000500063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009051402,"about_ca_system_score_gemma":0.0007180417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006505605,"about_ca_topic_score_gemma":0.002680444,"domain_scores_codex":[0.9956448,0.0004590695,0.001615061,0.001174181,0.0006279019,0.0004789681],"domain_scores_gemma":[0.9973161,0.0001891769,0.001101795,0.0005774084,0.0004684012,0.0003471303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001986536,0.0001991029,0.003987478,0.8152199,0.1391716,0.0000284428,0.000107729,1.31988e-7,8.881469e-9,0.000005923397,0.0005912,0.04066858],"study_design_scores_gemma":[0.000630434,0.00003058834,0.004619246,0.1595452,0.8228275,0.0002153524,0.00001956009,0.000002369556,6.159441e-8,0.000001285012,0.01157321,0.0005351663],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001669776,0.9858314,0.000001074127,0.000698275,0.00009370346,0.005669816,0.007598468,0.00002960542,0.00006090661],"genre_scores_gemma":[0.0002365685,0.9904559,0.0000188146,0.0008201003,0.0001016669,0.007409688,0.0001990435,0.00009216044,0.0006660469],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6836559,"threshold_uncertainty_score":0.9996629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2967367406","doi":"10.1038/s41523-019-0115-9","title":"Homologous recombination DNA repair defects in PALB2-associated breast cancers","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; McGill University; McGill Genome Centre; Jewish General Hospital","funders":"National Cancer Institute; Medical Research Council; National Health and Medical Research Council; Ministerstvo Zdravotnictví Ceské Republiky; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cycle for Survival; National Breast Cancer Foundation; National Institute for Health and Care Research; China Scholarship Council; Susan G. Komen; Univerzita Karlova v Praze; Ministry of Higher Education, Malaysia; NIHR Cambridge Biomedical Research Centre; European Commission; Breast Cancer Research Foundation; Cancer Australia; National Science Foundation","keywords":"PALB2; Genetics; Biology; Allele; Breast cancer; Germline mutation; Germline; Homologous recombination; Mutation; Gene; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.00452957797043336,"gpt":0.2255653187493903,"spread":0.221035740778957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002559721,0.0002204377,0.0002337808,0.00008586264,0.00004237858,0.00001746976,0.0001953015,0.000293813,0.000379446],"category_scores_gemma":[0.00002778765,0.0002312278,0.0001495979,0.0002246785,0.00003774573,0.00001103898,0.00009384067,0.0001527064,0.00005988465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004975941,"about_ca_system_score_gemma":0.0003093227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0015307,"about_ca_topic_score_gemma":0.002752719,"domain_scores_codex":[0.9984378,0.0001124274,0.0002380006,0.0005786141,0.0001974586,0.0004356953],"domain_scores_gemma":[0.9992074,0.0000115225,0.0001382931,0.0004141579,0.0001368582,0.00009171956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0005059524,0.0003003785,0.3426465,0.00008481718,0.0002499632,0.00003093212,0.0001319778,0.0007017248,0.6332037,0.0002016838,0.004911427,0.01703084],"study_design_scores_gemma":[0.004668273,0.0004651726,0.8828564,0.000265324,0.00007114459,0.0003182758,0.0001447189,0.001052205,0.1049368,0.0004203464,0.003770784,0.001030556],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956722,0.0003676048,0.00001003939,0.0002213951,0.0007411186,0.0003712708,0.0001533459,0.00008620485,0.002376771],"genre_scores_gemma":[0.9971657,0.0001349098,0.00005847467,0.0004172263,0.0001208545,0.0001272324,0.0001370532,0.00004843196,0.00179008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5402098,"threshold_uncertainty_score":0.9429197,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3007147204","doi":"10.1038/s41523-020-0149-z","title":"The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Niagara Health System; Centre Hospitalier de l’Université de Montréal; McMaster University; Ontario Clinical Oncology Group; Juravinski Hospital; Juravinski Cancer Centre; Nova Scotia Health Authority; Ottawa Regional Cancer Foundation; Capital District Health Authority; Ottawa Hospital; University of Ottawa; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Dalhousie University; University of Toronto","funders":"","keywords":"Medicine; Weight loss; Randomized controlled trial; Hazard ratio; Body mass index; Breast cancer; Overweight; Obesity; Internal medicine; Confidence interval; Letrozole; Cancer; Oncology; Physical therapy; Tamoxifen","retraction":null,"screen_n_in":null,"score":{"opus":0.0129633308557088,"gpt":0.3019813143102549,"spread":0.2890179834545461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003800423,0.0002075649,0.0007629159,0.00006256583,0.00005140831,0.00002267854,0.0001492394,0.00009831495,0.002079651],"category_scores_gemma":[0.00004286996,0.000128842,0.0003050757,0.0002993151,0.0002255917,0.00009835728,0.00005710305,0.0002857721,0.000008628358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002873997,"about_ca_system_score_gemma":0.0003111632,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01430165,"about_ca_topic_score_gemma":0.001753,"domain_scores_codex":[0.9982437,0.0001416811,0.0006278543,0.0003036101,0.0003838832,0.0002992422],"domain_scores_gemma":[0.9990816,0.0001153575,0.0002701328,0.0002159421,0.0001504341,0.0001665969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8757947,0.0002180428,0.02367687,0.0001099519,0.0002867196,0.00001417154,0.0005631899,0.00001356604,0.0004905773,0.0000971939,0.001557556,0.09717747],"study_design_scores_gemma":[0.8931197,0.0002935077,0.09846123,0.0004850972,0.0003751852,0.00006526186,0.0001215398,0.0003965277,0.0002669642,0.00004989391,0.006160259,0.0002048488],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9536628,0.00453695,0.00005265704,0.03651084,0.001489735,0.00213214,0.0007641445,0.00005854906,0.000792247],"genre_scores_gemma":[0.9944233,0.002779887,0.000008373722,0.0007138646,0.001291391,0.0004510459,0.00001555884,0.00003202627,0.0002845105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09697262,"threshold_uncertainty_score":0.9988326,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793956875","doi":"10.1038/s41523-018-0056-8","title":"Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort","year":2018,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"BC Cancer Agency; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences; Pathological Society of Great Britain and Ireland; National Institute for Health and Care Research; University of Cambridge; Cancer Research UK","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Nottingham Prognostic Index; Pathology; Hormone receptor; Lymph node; Cohort; Cancer; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01399216701025397,"gpt":0.2823321541672078,"spread":0.2683399871569538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002991282,0.0001814847,0.0003234056,0.00004140522,0.0001070324,0.00001592658,0.0001880986,0.0001032082,0.00005757432],"category_scores_gemma":[0.00001648575,0.0001382898,0.00006507027,0.0001740434,0.00021327,0.00000946793,0.00005975642,0.00008714983,0.000003416733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001047067,"about_ca_system_score_gemma":0.0001658847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001740989,"about_ca_topic_score_gemma":0.002546526,"domain_scores_codex":[0.9987358,0.0001414395,0.0003314339,0.0003764012,0.0001484445,0.0002664825],"domain_scores_gemma":[0.9991919,0.00002506673,0.0002451697,0.0002773173,0.0002181137,0.00004243097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000545811,0.000065113,0.956265,0.00002088527,0.0002603061,0.000001019603,0.0003027366,0.000003494496,0.02655832,0.0000696511,0.0006288278,0.01577003],"study_design_scores_gemma":[0.00050618,0.00002796082,0.9967483,0.00003387585,0.0002340959,0.0000341591,0.00005887959,0.000002808782,0.001723019,0.0000487239,0.0004472408,0.0001347199],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879881,0.004789542,0.00003593173,0.003757366,0.0001262893,0.0004078106,0.002614628,0.000007732006,0.0002726586],"genre_scores_gemma":[0.9953658,0.003227907,0.00008225631,0.0003153179,0.0005998703,0.0001955165,0.0001630297,0.00001811266,0.00003217002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0404833,"threshold_uncertainty_score":0.5639293,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2953595023","doi":"10.1038/s41523-019-0113-y","title":"LobSig is a multigene predictor of outcome in invasive lobular carcinoma","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"BC Cancer Agency; Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Metro North Hospital and Health Service; Cancer Institute NSW; National Breast Cancer Foundation; Cancer Research UK","keywords":"Nottingham Prognostic Index; Invasive lobular carcinoma; Oncology; Internal medicine; Medicine; Proportional hazards model; Breast cancer; Estrogen receptor; Gene expression profiling; Bioinformatics; Cancer; Gene; Biology; Gene expression; Genetics; Invasive ductal carcinoma","retraction":null,"screen_n_in":null,"score":{"opus":0.0117759063605308,"gpt":0.2577401540726026,"spread":0.2459642477120718,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005770298,0.0002212021,0.0003286775,0.00006067957,0.00002210631,0.0000058449,0.0001865842,0.0001350229,0.0003810929],"category_scores_gemma":[0.00001387268,0.000201137,0.0001175004,0.0001216988,0.00008146688,0.000006276301,0.0001413243,0.00007621352,0.00003109513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001071819,"about_ca_system_score_gemma":0.0001559306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002358691,"about_ca_topic_score_gemma":0.0007492916,"domain_scores_codex":[0.9987538,0.00003056088,0.0002936492,0.0004431746,0.0001815421,0.0002972368],"domain_scores_gemma":[0.9992462,0.00001370602,0.0001270408,0.0004198435,0.0001270416,0.00006614379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002488149,0.00009711542,0.9508379,0.00008083208,0.0001302755,0.000004551915,0.0002451487,0.00005708325,0.04659414,0.000006818704,0.0004752933,0.001222013],"study_design_scores_gemma":[0.002070335,0.00007048594,0.934632,0.0000561803,0.0000355435,0.00001648648,0.0001041305,0.00001536827,0.06178869,0.00001089019,0.001007455,0.0001924535],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955714,0.002233044,0.0000102294,0.0004484068,0.0002674433,0.0003177274,0.0006687207,0.000008572695,0.0004744014],"genre_scores_gemma":[0.9984891,0.0002054738,0.00009474731,0.0004741353,0.0001750958,0.0001027729,0.00004335981,0.00003072751,0.0003845579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01620594,"threshold_uncertainty_score":0.8202128,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2337607123","doi":"10.1038/npjbcancer.2016.9","title":"TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; National Cancer Institute; Conquer Cancer Foundation; National Institutes of Health; Geoffrey Beene Cancer Research Center; Breast Cancer Research Foundation","keywords":"Cytotoxicity; Cytotoxic T cell; Breast cancer; Tumor necrosis factor alpha; Medicine; Cancer; Immunology; Cancer research; Internal medicine; Biology; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.01033070288923425,"gpt":0.2413285627213564,"spread":0.2309978598321222,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001710467,0.0004706994,0.0005873257,0.0002289657,0.0001966044,0.00002167975,0.0003863205,0.0003472101,0.005722889],"category_scores_gemma":[0.00001616395,0.000330043,0.000147479,0.000356391,0.0002149098,0.0004258643,0.0002128031,0.0004226276,0.0004742778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005763638,"about_ca_system_score_gemma":0.0002295592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002471445,"about_ca_topic_score_gemma":0.0004740835,"domain_scores_codex":[0.9974623,0.0002534952,0.0004224385,0.0008111138,0.0001404972,0.0009101687],"domain_scores_gemma":[0.9988641,0.0001032697,0.0002811002,0.0004239204,0.0002347892,0.00009286694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006822964,0.0003046287,0.08787239,0.00002513327,0.0001359815,0.00001133752,0.0002371168,0.00000211136,0.8328395,0.00008301991,0.001174213,0.07663228],"study_design_scores_gemma":[0.004311661,0.00008101074,0.5718123,0.0002805014,0.00004461478,0.00004223827,0.00002089805,0.000001784043,0.4203174,0.00009353857,0.002540271,0.0004536839],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850855,0.0003559537,0.00003602966,0.008250147,0.001120351,0.0004171928,0.004439123,0.00009467856,0.0002010066],"genre_scores_gemma":[0.9964678,0.0005971604,0.00001700855,0.001427866,0.0002983447,0.0003552131,0.00003204704,0.00006787534,0.0007367281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.48394,"threshold_uncertainty_score":0.9999152,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2989510802","doi":"10.1038/s41523-019-0127-5","title":"The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada); University of British Columbia; University of Toronto; Royal Victoria Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Université Laval; BC Cancer Agency; Centre hospitalier universitaire de Québec; McGill University; Queen's University","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH Office of the Director; Servicio Gallego de Salud; National Cancer Institute; European Regional Development Fund; Cancer Council Victoria; Medical Research Council; European Commission; Lietuvos Mokslo Taryba; Canadian Institutes of Health Research; Imperial Experimental Cancer Medicine Centre; Division of Cancer Prevention, National Cancer Institute; National Institutes of Health; Freistaat Sachsen; Centro de Investigación Biomédica en Red de Cáncer; Federal Agency for Scientific Organizations; National Institute of General Medical Sciences; Deutschen Konsortium für Translationale Krebsforschung; KWF Kankerbestrijding; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Jewish General Hospital; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Memorial Sloan-Kettering Cancer Center; Istituto Oncologico Veneto; Institut National Du Cancer; National Health and Medical Research Council; Deutsche Krebshilfe; Fondazione Umberto Veronesi; Vetenskapsrådet; Stockholms Läns Landsting; Kuopion Yliopistollinen Sairaala; Ministero della Salute; McGill University; Generalitat de Catalunya; Cancer Center, University of Kansas; University of Southern California; Cancerfonden; Landspítali Háskólasjúkrahús; Ministerio de Economía y Competitividad; National Center for Advancing Translational Sciences; Bundesministerium für Bildung und Forschung; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Fondation ARC pour la Recherche sur le Cancer; American Cancer Society; Cancer Australia; Russian Foundation for Basic Research; Deutsche Gesetzliche Unfallversicherung; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; Programme Grants for Applied Research; Robert Bosch Stiftung; Associazione Italiana per la Ricerca sul Cancro; Karolinska Institutet; Hungarian Scientific Research Fund; Harvard T.H. Chan School of Public Health; Cancer Association of South Africa; Royal Marsden NHS Foundation Trust; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya; University of Cambridge; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; Government of Canada; Georgetown University; Breast Cancer Campaign; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Breast Cancer Foundation; National Institute of Environmental Health Sciences; Swedish Cancer Foundation; McGill University Health Centre; University of California, Irvine; David F. and Margaret T. Grohne Family Foundation; Deutsches Krebsforschungszentrum; World Cancer Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Fundación Mutua Madrileña; Breast Cancer Research Foundation; University of Chicago; NRG Oncology; Fondation du cancer du sein du Québec; Universitätsklinikum Hamburg-Eppendorf; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Institut Català de la Salut; University of Pennsylvania; Liga Portuguesa Contra o Cancro; University College London; Cancer Research UK; Beckman Research Institute, City of Hope; Susan G. Komen for the Cure; Beth Israel Deaconess Medical Center; Genome Canada; Brigham and Women's Hospital; Instituto de Salud Carlos III; Ohio State University; University of California, San Francisco; U.S. Department of Health and Human Services; Rheinische Friedrich-Wilhelms-Universität Bonn; Oak Foundation; Fisher Center for Alzheimer's Research Foundation; Fanconi Anemia Research Fund; Fonds Wetenschappelijk Onderzoek","keywords":"CHEK2; Breast cancer; PALB2; Triple-negative breast cancer; Biology; Cancer; Olaparib; Cancer research; Genetics; Internal medicine; Oncology; Medicine; Germline mutation; Mutation; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.00440340564138385,"gpt":0.2279491848363851,"spread":0.2235457791950013,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003386037,0.0002570834,0.0002918777,0.00002720208,0.0001548849,0.00003086153,0.0003178841,0.0001778504,0.0004080729],"category_scores_gemma":[0.00005546727,0.0001714949,0.000135225,0.0002056825,0.0001152696,0.00001039451,0.0001050182,0.0001927643,0.00001106377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001185541,"about_ca_system_score_gemma":0.0004130538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002535268,"about_ca_topic_score_gemma":0.001523129,"domain_scores_codex":[0.9983448,0.0001436306,0.0002841556,0.0004830241,0.0003278802,0.0004164757],"domain_scores_gemma":[0.9984474,0.00005198821,0.000480025,0.0005284992,0.0004024636,0.00008964185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00399086,0.0004488639,0.2834723,0.0001286399,0.005018554,0.00001434143,0.001547936,0.0008550028,0.6111933,0.0005124898,0.007898851,0.0849189],"study_design_scores_gemma":[0.00690543,0.0005617731,0.6608648,0.0005639035,0.0005391047,0.0001987404,0.000817059,0.001974069,0.3222407,0.0004022138,0.003814184,0.001117974],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993454,0.0006163624,0.0001358432,0.0006978391,0.0005092007,0.0005493585,0.002538604,0.00002886479,0.001469899],"genre_scores_gemma":[0.9957827,0.0004086248,0.0001356947,0.0002981322,0.0002091485,0.0001504355,0.00002841249,0.0000543008,0.002932492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3773925,"threshold_uncertainty_score":0.699336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2346853311","doi":"10.1038/npjbcancer.2016.7","title":"DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; National Institutes of Health","keywords":"Breast cancer; DNA methylation; Biology; Cancer; Epigenetics; genomic DNA; Gene; microRNA; Cancer research; Gene expression; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.008827057926447526,"gpt":0.2461827899611657,"spread":0.2373557320347182,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001551389,0.0003275268,0.0002892978,0.00003952918,0.0001309026,0.00005483284,0.0003813084,0.000157023,0.0003153832],"category_scores_gemma":[0.00002257192,0.0002115783,0.00007964197,0.0001093008,0.000136988,0.000008597909,0.0003935784,0.0001206818,0.000006570233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002401768,"about_ca_system_score_gemma":0.0003615742,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01207277,"about_ca_topic_score_gemma":0.02806492,"domain_scores_codex":[0.9980465,0.00009823773,0.0003250444,0.000821806,0.0002238465,0.0004845239],"domain_scores_gemma":[0.9988543,0.00006439092,0.0001498852,0.0006258339,0.0001232783,0.0001822839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0003084461,0.0001510847,0.4307757,0.000008260098,0.00008356874,0.000006482693,0.0002067135,0.0001691399,0.540621,0.0000025394,0.0009026267,0.02676442],"study_design_scores_gemma":[0.002494442,0.0001139453,0.9072341,0.0001449176,0.00008505331,0.00001494206,0.0001290501,0.00001192231,0.07701995,0.00005080959,0.0122838,0.000417027],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9687659,0.02453138,0.0001160157,0.002056759,0.0004941553,0.0005939156,0.003395231,0.00001170007,0.00003501731],"genre_scores_gemma":[0.9718757,0.02525393,0.00006121445,0.0006303795,0.00139347,0.000559416,0.00003622554,0.00005928293,0.0001303769],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4764584,"threshold_uncertainty_score":0.9945059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3043321283","doi":"10.1038/s41523-020-0171-1","title":"Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cure Brain Cancer Foundation","keywords":"Cyclophosphamide; Medicine; Metastatic breast cancer; Regimen; Breast cancer; Cancer; CD8; Immune system; Primary tumor; Oncology; Combination therapy; Cancer research; Concomitant; Blockade; Immunotherapy; Mammary tumor; Chemotherapy; Internal medicine; Immunology; Metastasis; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.01242845385308866,"gpt":0.26374376268641,"spread":0.2513153088333213,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000178573,0.0003378873,0.0007168481,0.0001293905,0.00007588958,0.00004104018,0.0001014178,0.00006936237,0.0008007066],"category_scores_gemma":[0.000009787885,0.000298939,0.00009365856,0.0003504103,0.0002070477,0.0002155912,0.00008379583,0.0002956114,0.000004338356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004277476,"about_ca_system_score_gemma":0.0005309207,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003998987,"about_ca_topic_score_gemma":0.0001932058,"domain_scores_codex":[0.998253,0.00006114502,0.0004533353,0.000580478,0.0002366167,0.0004153992],"domain_scores_gemma":[0.9991873,0.0000640025,0.0001731732,0.0002588497,0.00007135269,0.0002453178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005015703,0.000243882,0.8628054,0.0009226791,0.0007852192,0.0002361986,0.0004474382,0.0000621093,0.06371783,0.00001503695,0.0007320136,0.06501651],"study_design_scores_gemma":[0.007351753,0.0000817441,0.9876474,0.0003823431,0.0002400546,0.0004314886,0.0001043514,0.0003284082,0.0008022605,0.000005464116,0.002302064,0.0003227056],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9721717,0.01825994,0.00001253971,0.008133916,0.0001998936,0.0006281873,0.0003155135,0.00006191431,0.0002164044],"genre_scores_gemma":[0.9897698,0.00398721,0.0001737103,0.005528407,0.0002052203,0.0001332236,0.00002210935,0.00005853544,0.0001218126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.124842,"threshold_uncertainty_score":0.9999463,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3048442532","doi":"10.1038/s41523-020-00177-6","title":"Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; NODAL; Disease; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01040453626665588,"gpt":0.2591173577331325,"spread":0.2487128214664766,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005371717,0.0004516413,0.0004528178,0.00003597618,0.0001113484,0.00002384548,0.0002565214,0.00009741626,0.0002499429],"category_scores_gemma":[0.00002747167,0.0003918631,0.0002242443,0.0001744743,0.0002673666,0.0000186724,0.0001319214,0.0001164024,0.000006897272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001077036,"about_ca_system_score_gemma":0.0004501475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006143643,"about_ca_topic_score_gemma":0.00009895587,"domain_scores_codex":[0.9978676,0.00006803086,0.0003662134,0.0008438092,0.0003014486,0.0005528515],"domain_scores_gemma":[0.9986246,0.0000407694,0.0002147575,0.0003355459,0.0004604596,0.0003238552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06936897,0.001018693,0.4728393,0.0003995831,0.002432197,0.00004511082,0.0009705282,0.0003820778,0.3271598,0.00004872618,0.02659951,0.09873548],"study_design_scores_gemma":[0.004439726,0.0004066065,0.9500675,0.0001437712,0.0002607307,0.00002102109,0.0000942608,0.00003150539,0.03788307,0.00002084598,0.006045006,0.0005859525],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8963996,0.0298527,0.0004646168,0.03061057,0.000434325,0.002304461,0.03977534,0.00007277317,0.00008559941],"genre_scores_gemma":[0.9893072,0.003230031,0.0002853284,0.001674033,0.001846797,0.003132032,0.0003322631,0.00009076697,0.0001016009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4772282,"threshold_uncertainty_score":0.9998533,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3186156042","doi":"10.1038/s41523-021-00304-x","title":"Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"Breast Cancer Research Foundation","keywords":"CD68; Hazard ratio; Breast cancer; Medicine; Internal medicine; Adipose tissue; Immunohistochemistry; Confidence interval; Proportional hazards model; Cancer; Oncology; Endocrinology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.00974374986901148,"gpt":0.2713253308947841,"spread":0.2615815810257726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007069344,0.0003682776,0.0007789625,0.0001902484,0.0001141476,0.00004814984,0.0001169115,0.0001851855,0.001508924],"category_scores_gemma":[0.00001514859,0.0002692909,0.00009689561,0.0006244519,0.0001565652,0.0002725303,0.000105411,0.0003179091,0.000001232704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003349061,"about_ca_system_score_gemma":0.0006514452,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02331619,"about_ca_topic_score_gemma":0.01178324,"domain_scores_codex":[0.9978631,0.00007282166,0.0004473838,0.0005643963,0.0006068134,0.0004454771],"domain_scores_gemma":[0.9983376,0.00004575341,0.0003009449,0.000300963,0.0007304166,0.0002842804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002919539,0.0004826871,0.9801075,0.0001297421,0.0002590241,0.00001083402,0.001068431,0.00002586855,0.002613699,0.00001838053,0.0007401387,0.01425174],"study_design_scores_gemma":[0.00256127,0.00004701104,0.9900319,0.0004907109,0.000391946,0.0001014895,0.0002253809,0.000007595781,0.004961432,0.00001855802,0.0008631424,0.0002995701],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892765,0.002759454,0.000006292888,0.0009260291,0.0002917224,0.000486761,0.006121675,0.00004589138,0.0000857108],"genre_scores_gemma":[0.9979692,0.00096265,0.00008683501,0.0002523009,0.000216255,0.0001382512,0.0001677332,0.00005863855,0.0001481445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01395217,"threshold_uncertainty_score":0.9999759,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2544829712","doi":"10.1038/npjbcancer.2015.14","title":"αB-crystallin expression in breast cancer is associated with brain metastasis","year":2015,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Breast cancer; Brain metastasis; Immunohistochemistry; Oncology; Metastasis; Medicine; Proportional hazards model; Estrogen receptor; Cancer research; Internal medicine; Tissue microarray; Cancer; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02281297323245125,"gpt":0.3123760208703252,"spread":0.2895630476378739,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004715476,0.0002661214,0.0002919355,0.0001030227,0.00006505063,0.00004466172,0.0003072855,0.0002489131,0.0006651427],"category_scores_gemma":[0.00006117608,0.0002158185,0.0000694191,0.0003554283,0.0001094641,0.00001788511,0.0001868668,0.0002625315,0.00001348513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003442962,"about_ca_system_score_gemma":0.0009386325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003374939,"about_ca_topic_score_gemma":0.00307904,"domain_scores_codex":[0.9977583,0.0002211847,0.0002500474,0.0005994809,0.0005535253,0.000617441],"domain_scores_gemma":[0.9987493,0.00001602164,0.00008901602,0.0004312798,0.0003874622,0.0003269135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00203076,0.0004199213,0.1059514,0.00006194543,0.0003306346,0.00007223183,0.0004035445,0.0008021073,0.7863359,0.000005430225,0.06904531,0.03454076],"study_design_scores_gemma":[0.01344599,0.0006010975,0.251715,0.001319035,0.0001084241,0.000372349,0.0006029311,0.0009002169,0.6331208,0.00009917645,0.0956382,0.002076849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855759,0.001565738,0.0002500015,0.009325052,0.00009840152,0.0005233578,0.001721226,0.00003151776,0.000908857],"genre_scores_gemma":[0.9959609,0.0001895648,0.0001507636,0.001038406,0.0002778877,0.0004090194,0.0001068441,0.00006676541,0.00179983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1532152,"threshold_uncertainty_score":0.8800822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2985910591","doi":"10.1038/s41523-019-0138-2","title":"Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute for Health and Care Research; Breast Cancer Research Foundation","keywords":"Menstrual cycle; Breast cancer; Endocrinology; Internal medicine; Progesterone receptor; Gene expression; Estrogen; Hormone; Cancer; Hormone receptor; Medicine; Biology; Estrogen receptor; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.002844894497142223,"gpt":0.2262877004075637,"spread":0.2234428059104214,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000186178,0.0003226724,0.0003452216,0.0001223678,0.00005277679,0.00002213013,0.0002104438,0.0005932826,0.0003230096],"category_scores_gemma":[0.000008925605,0.0002933996,0.00009943576,0.0003133744,0.00006674912,0.00001673688,0.0001311108,0.0003682438,0.00004761059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002879343,"about_ca_system_score_gemma":0.0001850926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001280527,"about_ca_topic_score_gemma":0.0005075699,"domain_scores_codex":[0.9980845,0.0001721893,0.000294316,0.0006269186,0.0002304232,0.0005916765],"domain_scores_gemma":[0.9993002,0.00001431732,0.0001690715,0.0002744277,0.00009963588,0.0001423284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0005924631,0.0001571305,0.1134648,0.00001020215,0.0001266796,0.00001356498,0.0001509642,0.0004887313,0.8800839,0.000003387064,0.0005498725,0.004358214],"study_design_scores_gemma":[0.004458867,0.0002215704,0.5318968,0.0003629458,0.00004087984,0.00008973906,0.0001078511,0.0002906117,0.4617097,0.00001324704,0.0002107058,0.000597036],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930779,0.004009268,0.00000124475,0.0007953726,0.0003826906,0.0004890894,0.000825081,0.00002793384,0.0003914047],"genre_scores_gemma":[0.9967373,0.001855687,0.00003624434,0.0001834603,0.0001756852,0.0001593894,0.0003454094,0.00006207642,0.0004447583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.418432,"threshold_uncertainty_score":0.9999518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3153071119","doi":"10.1038/s41523-021-00251-7","title":"Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute for Health and Care Research; Astex Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; AstraZeneca; National Cancer Institute; National Institutes of Health; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Fulvestrant; PTEN; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Anastrozole; Cancer; Aromatase inhibitor; Cancer research; Estrogen receptor; PI3K/AKT/mTOR pathway; Biology; Aromatase; Signal transduction","retraction":null,"screen_n_in":null,"score":{"opus":0.007119816247072573,"gpt":0.2537711970203723,"spread":0.2466513807732997,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001916187,0.0003942527,0.0004237906,0.0001371019,0.00007594695,0.00005136174,0.0001909889,0.0001792357,0.0002324092],"category_scores_gemma":[0.00002276041,0.0003720931,0.00009332137,0.0006444713,0.0001500138,0.00003284375,0.00007822329,0.000351836,0.000005240043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000697564,"about_ca_system_score_gemma":0.001456692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004627367,"about_ca_topic_score_gemma":0.01690862,"domain_scores_codex":[0.9975281,0.0002107199,0.0004136353,0.0008708821,0.0003751797,0.0006014284],"domain_scores_gemma":[0.9987625,0.0000309003,0.0001770138,0.000349628,0.0005222887,0.0001577063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002103702,0.0008245072,0.06496813,0.0001476697,0.0003551264,0.0003756418,0.0005463673,0.004209527,0.9120866,0.00006396313,0.0003973548,0.01392138],"study_design_scores_gemma":[0.00598568,0.0003026643,0.2681973,0.0008935498,0.0001316259,0.0004726997,0.0003933942,0.0005253923,0.7217966,0.0001052738,0.0003778109,0.0008179587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932514,0.002422903,0.0002737988,0.001733782,0.0003225156,0.0004787309,0.001271044,0.00002150665,0.0002243243],"genre_scores_gemma":[0.9977775,0.0002966049,0.0001706233,0.0006265066,0.000278648,0.0004699872,0.0001798245,0.00007195625,0.0001283055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2032292,"threshold_uncertainty_score":0.9998731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3128758614","doi":"10.1038/s41523-021-00222-y","title":"Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"European Organisation for Research and Treatment of Cancer; University of Nottingham; National Institute for Health and Care Research; Cancer Research UK; AstraZeneca","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Endocrine system; Internal medicine; Hormone; Hormone receptor; Cancer; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.06251399066135013,"gpt":0.3651663009465171,"spread":0.302652310285167,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000161743,0.0009506437,0.002503944,0.0002582048,0.0001795662,0.00006260722,0.0003013145,0.0001469837,0.01243557],"category_scores_gemma":[0.00001776111,0.000757443,0.001047447,0.001098453,0.0004868236,0.0004995615,0.0001188411,0.0005096382,0.0000362943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009191453,"about_ca_system_score_gemma":0.0007737121,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01053362,"about_ca_topic_score_gemma":0.0004068917,"domain_scores_codex":[0.9955514,0.0002523421,0.001037849,0.001135823,0.001027179,0.0009953725],"domain_scores_gemma":[0.9964921,0.0002010618,0.0006247841,0.0008839587,0.001355775,0.0004423454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02496611,0.001371034,0.005493799,0.0003312195,0.08431081,0.0002301357,0.001100582,0.0007383855,0.7940795,0.00007223996,0.006992655,0.08031347],"study_design_scores_gemma":[0.04156357,0.001097436,0.1637208,0.0007034816,0.05548643,0.001973732,0.001462228,0.0005103799,0.7193633,0.0001169635,0.01146629,0.002535416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7440071,0.1751973,0.001821964,0.03315531,0.001772818,0.002679902,0.03807301,0.0006000972,0.002692559],"genre_scores_gemma":[0.9857139,0.004114951,0.001671967,0.001253175,0.0006534326,0.0008999275,0.0005158797,0.0002509452,0.004925836],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2417068,"threshold_uncertainty_score":0.9994876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2587895918","doi":"10.1038/s41523-016-0003-5","title":"Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Cancer Research UK; Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Oncology; Medicine; Breast cancer; Internal medicine; Gene signature; Druggability; Tamoxifen; Cohort; Hazard ratio; Cancer; Bioinformatics; Gene; Biology; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.01088319988354979,"gpt":0.296361716873941,"spread":0.2854785169903912,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001330389,0.0003565939,0.0004112843,0.00007337587,0.0003252748,0.0000665801,0.0005616504,0.0001264538,0.0002738711],"category_scores_gemma":[0.00002694953,0.00031287,0.0001197067,0.000083235,0.0004103032,0.00003090313,0.000188418,0.0001059862,0.0000117097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009429546,"about_ca_system_score_gemma":0.0002182907,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01224036,"about_ca_topic_score_gemma":0.003824285,"domain_scores_codex":[0.9980885,0.00005149646,0.0003944403,0.0006881935,0.0003880234,0.0003893513],"domain_scores_gemma":[0.9978296,0.00001071459,0.0004172238,0.00103424,0.0005288811,0.0001793324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0009563182,0.0001913213,0.1404937,0.0001260756,0.0009631488,0.0000128807,0.00115787,0.0002647041,0.8152941,0.0004762883,0.008904303,0.03115921],"study_design_scores_gemma":[0.001038461,0.00005996379,0.8442724,0.0002034149,0.0001595765,0.00002017013,0.0002164144,0.000007116991,0.1530696,0.0001502074,0.0004804582,0.0003221298],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793998,0.002059237,0.0002315349,0.01411167,0.0007403088,0.0005067195,0.001534837,0.00002704464,0.001388815],"genre_scores_gemma":[0.9975116,0.0004182687,0.0000942828,0.0003105523,0.0006715897,0.0003645661,0.00007969984,0.00004767725,0.0005017558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7037787,"threshold_uncertainty_score":0.9999323,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3184508197","doi":"10.1038/s41523-021-00307-8","title":"Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Trastuzumab; Pertuzumab; Docetaxel; Internal medicine; Oncology; Tamoxifen; Population; Prospective cohort study; Gynecology; Cohort; Amenorrhea; Cancer; Pregnancy","retraction":null,"screen_n_in":null,"score":{"opus":0.009360194591843056,"gpt":0.2740110520630102,"spread":0.2646508574711672,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001366276,0.0002475109,0.000682549,0.00007510454,0.00005456825,0.000006224665,0.00006146054,0.0001155193,0.0008382605],"category_scores_gemma":[0.00001053308,0.0001725012,0.00004354645,0.0004543611,0.0001689542,0.00009739113,0.00003256582,0.0002231841,0.000003336809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001501499,"about_ca_system_score_gemma":0.0006794215,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008458297,"about_ca_topic_score_gemma":0.004220498,"domain_scores_codex":[0.9981809,0.0001153673,0.0003242828,0.0007906863,0.000226763,0.0003619753],"domain_scores_gemma":[0.9987658,0.00001563257,0.0001257657,0.0005124777,0.0004653195,0.0001149638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01380709,0.002859066,0.9628889,0.0000362938,0.001167257,0.0001212887,0.005974248,0.00007156741,0.002440485,0.000004374846,0.000008268919,0.01062117],"study_design_scores_gemma":[0.00637016,0.0006732083,0.9890339,0.00009721711,0.0002356744,0.0005235312,0.002156787,0.00007322275,0.0006122269,0.0000521549,0.000008768605,0.0001631702],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955381,0.0007708071,0.000003393288,0.0006665118,0.0001387134,0.001420326,0.000202692,0.00003743059,0.001222024],"genre_scores_gemma":[0.9970618,0.0001402674,0.00001099795,0.00004187453,0.000103048,0.001411761,0.0000132207,0.00002689596,0.00119012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02614499,"threshold_uncertainty_score":0.9981444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3215126804","doi":"10.1038/s41523-021-00355-0","title":"Acupuncture versus cognitive behavioral therapy for pain among cancer survivors with insomnia: an exploratory analysis of a randomized clinical trial","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Sleep and related disorders","field":"Psychology","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland","funders":"H2020 European Research Council; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Patient-Centered Outcomes Research Institute","keywords":"Insomnia; Medicine; Acupuncture; Randomized controlled trial; Physical therapy; Cancer pain; Quality of life (healthcare); Cognitive behavioral therapy for insomnia; Cognitive behavioral therapy; Internal medicine; Cancer; Psychiatry; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05913880391179745,"gpt":0.4063188602243494,"spread":0.347180056312552,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001641863,0.0003407996,0.001564266,0.0002047002,0.00008841417,0.00002546524,0.0001592956,0.0004666133,0.003408982],"category_scores_gemma":[0.0001062113,0.0002111391,0.0009450613,0.0009071915,0.0005120484,0.000127335,0.00001855039,0.0003538129,0.000002055968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005630063,"about_ca_system_score_gemma":0.0003857992,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005433142,"about_ca_topic_score_gemma":0.03791014,"domain_scores_codex":[0.9958615,0.002131668,0.0006837694,0.0006641636,0.0002920325,0.000366893],"domain_scores_gemma":[0.9968776,0.001539158,0.0004246449,0.0003586487,0.0006321053,0.000167857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8254928,0.001928821,0.06501187,0.000006309246,0.02360808,0.00001916958,0.004287756,0.0001221055,0.000008945891,0.0000222585,0.0002717789,0.07922012],"study_design_scores_gemma":[0.9387347,0.001038171,0.03137119,0.00006237951,0.01740436,0.000001472674,0.01031145,0.0002794912,0.00002636377,0.00001379725,0.000334037,0.0004225403],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911533,0.002837355,0.0009751396,0.0002147175,0.002352227,0.001536333,0.0006747313,0.00005002544,0.0002061502],"genre_scores_gemma":[0.9952656,0.0008218336,0.00003746695,0.000401267,0.0004180259,0.002563059,0.0002770296,0.00005677682,0.000158913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.113242,"threshold_uncertainty_score":0.997502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3164338067","doi":"10.1038/s41523-021-00266-0","title":"Anti-tumor effects of an ID antagonist with no observed acquired resistance","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"European Social Fund; Fonds de Recherche du Québec - Santé; National Cancer Institute; National Institutes of Health; Botwinick-Wolfensohn Foundation; Fonds de recherche du Québec – Nature et technologies; American Concrete Institute Foundation; Generalitat Valenciana; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation","keywords":"Paclitaxel; Cancer research; Biology; Reactive oxygen species; Transcription factor; Cell growth; Cancer; Cell biology; Biochemistry; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.006295913903447121,"gpt":0.2335889986771677,"spread":0.2272930847737206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004669369,0.0001756422,0.00022336,0.00001523836,0.00007065025,0.0000261972,0.0001951501,0.00007121034,0.00008941966],"category_scores_gemma":[0.00003966381,0.0001594262,0.00006111046,0.0001041723,0.000131132,0.000007974792,0.00006210872,0.00003987471,0.000004936895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002282399,"about_ca_system_score_gemma":0.0004349458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005581092,"about_ca_topic_score_gemma":0.0002935824,"domain_scores_codex":[0.9988992,0.00007291756,0.0001709947,0.00042877,0.0001848813,0.0002432826],"domain_scores_gemma":[0.9989475,0.00001456261,0.0001187147,0.0005228192,0.0002918573,0.000104543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005718936,0.0001892286,0.01444045,0.0003291038,0.0001039612,0.00008542748,0.00001542495,0.00004628802,0.982781,0.00000814212,0.000989504,0.0004395829],"study_design_scores_gemma":[0.0009209188,0.00008538421,0.1588528,0.0001907035,0.00005322099,0.00002916933,0.00001370879,0.000009403288,0.8332027,0.000003873127,0.006428659,0.0002094459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958188,0.003182081,0.00006322068,0.00007963994,0.0001865213,0.0001256579,0.000229414,0.000021715,0.0002929325],"genre_scores_gemma":[0.9975958,0.00004732161,0.0007342916,0.0003670459,0.0003439403,0.00005086311,0.0001875602,0.00003993542,0.0006332232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1495783,"threshold_uncertainty_score":0.6501211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008259997","doi":"10.1038/s41523-020-0148-0","title":"The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epirubicin; Cyclophosphamide; Internal medicine; Oncology; Anthracycline; Hazard ratio; Breast cancer; Chemotherapy; Adjuvant chemotherapy; Fluorouracil; Clinical endpoint; Proportional hazards model; Adjuvant; Methotrexate; Randomized controlled trial; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.006323787954146343,"gpt":0.2503081837815237,"spread":0.2439843958273774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001157973,0.0003552423,0.0003314429,0.00004118316,0.000246156,0.00004521898,0.0002422293,0.0001223839,0.00006828576],"category_scores_gemma":[0.00003213,0.000261054,0.00007162864,0.0002532731,0.0001673401,0.00001111415,0.0001454889,0.0001439317,0.00000718896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001474172,"about_ca_system_score_gemma":0.0003110144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002552492,"about_ca_topic_score_gemma":0.001294683,"domain_scores_codex":[0.9981129,0.0001252688,0.0003010553,0.0007346626,0.0002524837,0.000473614],"domain_scores_gemma":[0.9990304,0.00003748917,0.0001616491,0.0003185828,0.0002462336,0.0002056806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009250366,0.0002609169,0.8294933,0.00005499015,0.0001897113,0.000004395481,0.0003189212,0.0003619883,0.0367825,0.000004066579,0.001946478,0.1213323],"study_design_scores_gemma":[0.004262018,0.0001871279,0.9451895,0.0000742699,0.00005113958,0.00000537152,0.00005720999,0.00006349866,0.04613006,0.000006838528,0.003634784,0.000338231],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9721047,0.002297104,0.00005700024,0.02102817,0.0002325049,0.0008729059,0.003363349,0.00002671461,0.00001751874],"genre_scores_gemma":[0.9936405,0.00138446,0.0001588278,0.003056374,0.0004879141,0.001078746,0.00008681735,0.00006511561,0.0000412727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1209941,"threshold_uncertainty_score":0.9999841,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2470412971","doi":"10.1038/npjbcancer.2016.22","title":"The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"BC Cancer Agency; Cancer Research UK","keywords":"Subtyping; Breast cancer; Oncology; Medicine; Internal medicine; Population; Cancer; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.009950373896513452,"gpt":0.2853044309289292,"spread":0.2753540570324157,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001873191,0.0002314279,0.0007049521,0.0002754784,0.00009498047,0.00001242874,0.0001630887,0.0001105697,0.001065359],"category_scores_gemma":[0.000006951611,0.0001276083,0.0004214435,0.0009944437,0.0002308189,0.00009038459,0.00003679278,0.0000896568,0.000001877838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001851767,"about_ca_system_score_gemma":0.0001629328,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05078248,"about_ca_topic_score_gemma":0.001640907,"domain_scores_codex":[0.9981893,0.00010146,0.0006271437,0.0002993921,0.0004801721,0.0003025247],"domain_scores_gemma":[0.9981527,0.0000990274,0.0006172159,0.0005393573,0.0004846754,0.0001070674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01695788,0.0002060966,0.3464758,0.00004867448,0.00732848,0.000006806192,0.0001800153,0.0000336405,0.1170801,0.00004455722,0.000492258,0.5111458],"study_design_scores_gemma":[0.01046696,0.0001322243,0.9809431,0.000307754,0.003062471,0.00002623114,0.0000850577,0.0003740429,0.003723223,0.00001811982,0.0006857768,0.0001749991],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890975,0.004754405,0.00025339,0.002283656,0.0002403753,0.0003569582,0.002934255,0.00002744544,0.00005197853],"genre_scores_gemma":[0.9964622,0.002993488,0.00002909063,0.0001672398,0.00009013266,0.00007242963,0.000047833,0.00002931607,0.0001083171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6344674,"threshold_uncertainty_score":0.9998478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3167217140","doi":"10.1038/s41523-021-00275-z","title":"Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Université Laval; McMaster University; Juravinski Cancer Centre; University of British Columbia; Saint John Regional Hospital; Roche (Canada); BC Cancer Agency; Niagara Health System; Grand River Hospital; Queen's University; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Metformin; Placebo; Medicine; Breast cancer; Oncology; Internal medicine; Randomized controlled trial; Cancer; Insulin; Pathology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0101743293740794,"gpt":0.2891731375598405,"spread":0.2789988081857611,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001074342,0.0003653971,0.0009447515,0.0000742109,0.00006462789,0.00003387334,0.0003445969,0.0002214191,0.000843506],"category_scores_gemma":[0.0001602053,0.0002293757,0.0004811828,0.0002848389,0.0001636945,0.00001123036,0.00007076755,0.0002276066,0.000005144872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005301176,"about_ca_system_score_gemma":0.000396175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001044875,"about_ca_topic_score_gemma":0.0006678285,"domain_scores_codex":[0.9972129,0.0009699824,0.0004415586,0.0005101084,0.0004194081,0.0004460223],"domain_scores_gemma":[0.9986978,0.0002976225,0.0002225439,0.0005484935,0.0001386232,0.00009492833],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7725384,0.0001994587,0.001009543,0.00009931414,0.0007900801,0.000007005394,0.0002381827,0.0001847113,0.01096981,0.0001970145,0.001460336,0.2123062],"study_design_scores_gemma":[0.6654487,0.0003079777,0.003029778,0.0001008369,0.0007843172,0.00002177251,0.0001455263,0.00002955226,0.2682924,0.00002149107,0.06131107,0.0005065805],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9000964,0.09541532,0.000007713246,0.0001520287,0.001881881,0.0009142474,0.0006667366,0.000009267205,0.0008564254],"genre_scores_gemma":[0.962799,0.03401212,0.00001130797,0.0004006231,0.001379578,0.00104496,0.0001043697,0.00004585556,0.0002021963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2573226,"threshold_uncertainty_score":0.935367,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3169325545","doi":"10.1038/s41523-021-00281-1","title":"Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Menarini Silicon Biosystems; Fashion Footwear Association of New York","keywords":"Medicine; Metastatic breast cancer; Circulating tumor cell; Internal medicine; Oncology; Progression-free survival; Clinical endpoint; Estrogen receptor; Cancer; Breast cancer; Metastasis; Chemotherapy; Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.01154970527360109,"gpt":0.2841936666187084,"spread":0.2726439613451073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009836131,0.0003205178,0.0005844243,0.00009531934,0.00007361698,0.00004492467,0.00006517089,0.00004506433,0.004911175],"category_scores_gemma":[0.000009021584,0.000281272,0.0001239981,0.0004590562,0.00008046017,0.0001693164,0.00007300666,0.000315578,0.00001394997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000411938,"about_ca_system_score_gemma":0.0005087336,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008821706,"about_ca_topic_score_gemma":0.001060549,"domain_scores_codex":[0.9979715,0.0000887162,0.0003950786,0.0005894281,0.000429963,0.0005252862],"domain_scores_gemma":[0.9988953,0.00005059814,0.0001562249,0.0002549581,0.0003922429,0.000250705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004631578,0.0006521805,0.8833104,0.0002158554,0.0002164154,0.0003865095,0.0005574324,0.00005351824,0.005773595,0.00001071454,0.000435466,0.1079247],"study_design_scores_gemma":[0.007472955,0.00003538073,0.9830522,0.0004246265,0.0001779834,0.000984261,0.0002312342,0.0001145028,0.005667715,0.00002899951,0.001482472,0.0003276935],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909198,0.003111336,0.00001916803,0.001648281,0.0003448004,0.0004740979,0.001105402,0.00002888165,0.002348224],"genre_scores_gemma":[0.9947926,0.001411838,0.000164386,0.002476301,0.0002737654,0.0001877884,0.00005898525,0.00006735605,0.000567026],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1075971,"threshold_uncertainty_score":0.9999639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3181590127","doi":"10.1038/s41523-021-00299-5","title":"High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Ministry of Science and Technology, Taiwan; National Taiwan University Hospital; National Research Foundation Singapore; Cancer Research UK; BC Cancer Agency; Ministry of Education; National Taiwan University; Ministry of Education - Singapore; National Research Foundation; Ministry of Health and Welfare","keywords":"Breast cancer; Copy-number variation; Medicine; Oncology; Estrogen receptor; Cancer; Incidence (geometry); Immune system; Gene; East Asia; Internal medicine; Cancer research; Biology; Immunology; Genetics; China","retraction":null,"screen_n_in":null,"score":{"opus":0.01025724411300611,"gpt":0.2576346292176395,"spread":0.2473773851046334,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002704717,0.000269075,0.0005928242,0.0002163878,0.00005722046,0.00003021232,0.0001662712,0.0001378168,0.003466191],"category_scores_gemma":[0.00002514559,0.0002671615,0.0001103809,0.0008555565,0.0001929647,0.0002660513,0.00006077031,0.0003643412,0.000007709254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002131433,"about_ca_system_score_gemma":0.001569423,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02083165,"about_ca_topic_score_gemma":0.01316169,"domain_scores_codex":[0.9975474,0.0001000964,0.0005963747,0.0005898231,0.0004967926,0.0006694891],"domain_scores_gemma":[0.9987938,0.00002331937,0.000172985,0.0004213088,0.0002916886,0.0002968632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004895781,0.0003260993,0.980141,0.0007172297,0.00008716089,0.00009241507,0.002325857,0.0006712227,0.00209793,0.00007989979,0.0006174755,0.01235413],"study_design_scores_gemma":[0.002235316,0.00007269003,0.9918953,0.00138973,0.00008291335,0.0003052668,0.001350012,0.0004116671,0.001819311,0.00002862977,0.0001547231,0.0002544326],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934964,0.00127762,0.00002414208,0.00244713,0.0004500084,0.0004069297,0.0005588111,0.00002996326,0.001309051],"genre_scores_gemma":[0.9966958,0.0006264047,0.0001042481,0.0002750731,0.0003653358,0.0007835376,0.00002916917,0.0000407737,0.001079627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0120997,"threshold_uncertainty_score":0.9999781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308569225","doi":"10.1038/s41523-022-00488-w","title":"Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"AI in cancer detection","field":"Computer Science","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Innovative Medicines Initiative; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; European Commission; Puma Biotechnology; AstraZeneca; Myriad Genetics; European Federation of Pharmaceutical Industries and Associations; Daiichi Sankyo Europe; Horizon 2020 Framework Programme; Knut och Alice Wallenbergs Stiftelse; Bristol-Myers Squibb","keywords":"Pleomorphism (cytology); Grading (engineering); Breast cancer; Limiting; Artificial intelligence; Pathology; Radiology; Medicine; Computer science; Cancer; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01140063136058184,"gpt":0.2521539765656102,"spread":0.2407533452050284,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003934997,0.0002644507,0.0003047383,0.0002775117,0.0006402989,0.0001447563,0.0009186309,0.0000807274,0.001298814],"category_scores_gemma":[0.000008550864,0.0003062592,0.000111329,0.00101109,0.00005410685,0.0006231457,0.0005458546,0.0005777587,0.00001831929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002060749,"about_ca_system_score_gemma":0.0002799408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004707742,"about_ca_topic_score_gemma":0.0006047278,"domain_scores_codex":[0.9974794,0.0001376759,0.0003618174,0.0007968202,0.0005379091,0.0006863139],"domain_scores_gemma":[0.9989843,0.00006645791,0.0002413469,0.0004333449,0.0001458742,0.000128618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.000499545,0.0001604149,0.03422483,0.0001361543,0.0001136742,0.00004525275,0.002597478,0.4057404,0.004797319,0.001392022,0.003701733,0.5465912],"study_design_scores_gemma":[0.001446091,0.00007563707,0.1343648,0.00009107369,0.00001886122,0.000379961,0.0001844417,0.8485293,0.0001273789,0.0001787062,0.01411358,0.0004902526],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7197241,0.006083113,0.1672222,0.0605809,0.02522569,0.005191809,0.001050432,0.01167145,0.003250313],"genre_scores_gemma":[0.9955524,0.0001065269,0.001568302,0.0008091052,0.0004559624,0.001274736,0.000005826084,0.00007509015,0.0001520437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.546101,"threshold_uncertainty_score":0.999939,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390607200","doi":"10.1038/s41523-023-00607-1","title":"Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"BC Cancer Foundation; Canadian Institutes of Health Research; Susan G. Komen; Government of Canada; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Liquid biopsy; Oncology; Biopsy; Internal medicine; Neoadjuvant therapy; Circulating tumor DNA; Minimal residual disease; Pathology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.008582745815151772,"gpt":0.3189100114348784,"spread":0.3103272656197266,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003265816,0.0002186734,0.0001768145,0.000149579,0.0000846234,0.0001128917,0.0001225239,0.0001369093,0.0002195964],"category_scores_gemma":[0.00005868976,0.0002283926,0.00006038083,0.0003280257,0.00003182149,0.00002113219,0.0000662227,0.0001655274,0.0000173196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005803159,"about_ca_system_score_gemma":0.0007599364,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007703719,"about_ca_topic_score_gemma":0.009325294,"domain_scores_codex":[0.9984894,0.0001278485,0.0002695413,0.0006041965,0.0001951963,0.0003137499],"domain_scores_gemma":[0.9993423,0.00004707817,0.00006601139,0.0002256849,0.0001554187,0.0001634782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001314536,0.00006162329,0.001536636,0.00004229572,0.00005723316,0.00007194654,0.0003834297,0.006368885,0.8093375,0.00003574407,0.0002692784,0.1805209],"study_design_scores_gemma":[0.001758412,0.000590459,0.7483287,0.000381467,0.00009321784,0.0006637697,0.0005392332,0.007663199,0.2332009,0.000296358,0.005677169,0.0008070298],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935836,0.0005830909,0.001977064,0.001534268,0.0009180881,0.0004610264,0.0007260395,0.00002828445,0.0001885466],"genre_scores_gemma":[0.997466,0.0001561662,0.0002122399,0.0005471022,0.0008657961,0.000424537,0.00005122202,0.00005417217,0.0002227971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7467921,"threshold_uncertainty_score":0.998904,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402494964","doi":"10.1038/s41523-024-00679-7","title":"Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Breast Cancer Foundation; Breast Cancer Research Foundation","keywords":"Pembrolizumab; Oncology; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Immunotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.008130626764051447,"gpt":0.2726968127594168,"spread":0.2645661859953653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002906122,0.0002531791,0.0006805791,0.0000617839,0.00008140607,0.00003550354,0.0001626195,0.00007589122,0.0002512049],"category_scores_gemma":[0.00003013455,0.0001345215,0.0002288321,0.0002689128,0.0001606301,0.00009175974,0.00001705919,0.0001581019,0.000002350241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002476682,"about_ca_system_score_gemma":0.0003430797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002151915,"about_ca_topic_score_gemma":0.0003851362,"domain_scores_codex":[0.9983011,0.00007965147,0.0004895122,0.0004446452,0.000430229,0.0002548303],"domain_scores_gemma":[0.9987448,0.0003371021,0.0001754174,0.0004684505,0.0002103602,0.00006390832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7960966,0.0003857267,0.001178834,0.00006573508,0.001623312,0.00000483043,0.004262264,0.00002109538,0.0003002585,0.000007738056,0.00224648,0.1938072],"study_design_scores_gemma":[0.8057844,0.001180312,0.1784491,0.0008398788,0.0006991841,0.000007966366,0.001065537,0.0004207083,0.0004471594,0.00004607896,0.01077553,0.0002841238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835616,0.002317113,0.0001711635,0.006785038,0.0006716936,0.004439123,0.001380299,0.00008932005,0.0005846266],"genre_scores_gemma":[0.9972268,0.0002370249,0.0001375083,0.0008879655,0.0003281154,0.0005881168,0.0001128158,0.00006336383,0.000418232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.193523,"threshold_uncertainty_score":0.5485629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3160306401","doi":"10.1038/s41523-021-00255-3","title":"Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sinai Health System; Université Laval; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Instituto de Salud Carlos III; Medical Research Council; Freistaat Sachsen; Unicancer; Canadian Institutes of Health Research; Direction Générale de l’offre de Soins; Universität Leipzig; National Health and Medical Research Council; Institut National Du Cancer; Agence Nationale de la Recherche; Cancer Australia; European Regional Development Fund; National Breast Cancer Foundation; Fundación Cellex; European Commission; University of Cambridge; Cancer Research UK; Centres de Recerca de Catalunya; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Government of Canada; Fondation du cancer du sein du Québec; Generalitat de Catalunya; National Institute for Health and Care Research; Genome Canada; Cancer Council Victoria; Deutsche Krebshilfe; Victorian Cancer Agency","keywords":"Breast cancer; Missense mutation; Germline mutation; Germline; Allele; Male breast cancer; Haploinsufficiency; Penetrance; Genetics; Biology; PALB2; Cancer; Oncology; Cancer research; Medicine; Mutation; Gene; Phenotype","retraction":null,"screen_n_in":null,"score":{"opus":0.02590124000455008,"gpt":0.3266547738514796,"spread":0.3007535338469295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005787089,0.000165617,0.0003765916,0.0001038143,0.00002626356,0.000008740745,0.0001660897,0.00010518,0.0007526537],"category_scores_gemma":[0.00007096896,0.0001241467,0.00007973609,0.0004063373,0.00005626331,0.000143796,0.00006806745,0.0001801038,4.387307e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001158065,"about_ca_system_score_gemma":0.0009471825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002661482,"about_ca_topic_score_gemma":0.01632343,"domain_scores_codex":[0.9970443,0.0003219603,0.0004942485,0.0003400917,0.001615289,0.0001840766],"domain_scores_gemma":[0.9963283,0.00003698776,0.0005038867,0.000370865,0.002703541,0.00005643645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001007245,0.003204761,0.9687635,0.00008279274,0.0005013642,0.000003890158,0.001609421,0.003113729,0.01328382,0.000001605206,0.00002967296,0.008398185],"study_design_scores_gemma":[0.01047957,0.0002499826,0.9773876,0.0005547448,0.0005194516,0.00007082531,0.0003606914,0.003596484,0.006666663,0.000004786722,0.000005477399,0.0001037473],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966542,0.0001544143,0.00001544113,0.0005263646,0.0007848013,0.0008377702,0.0008431287,0.000008592125,0.0001753393],"genre_scores_gemma":[0.9992765,0.00004303246,0.00009137524,0.00007987185,0.0001903945,0.0001948387,0.00003606057,0.00002551214,0.00006239018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01366195,"threshold_uncertainty_score":0.9108856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3136326764","doi":"10.1038/s41523-021-00238-4","title":"Co-dependency for MET and FGFR1 in basal triple-negative breast cancers","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Genome Canada; Canadian Institutes of Health Research; Deutsches Krebsforschungszentrum; Genentech; McGill University","keywords":"Triple-negative breast cancer; Cancer research; Fibroblast growth factor receptor 1; Breast cancer; Basal (medicine); Carcinogenesis; Medicine; Biology; Cancer; Oncology; Internal medicine; Receptor; Fibroblast growth factor","retraction":null,"screen_n_in":null,"score":{"opus":0.01924902441114627,"gpt":0.3203543716024577,"spread":0.3011053471913114,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001964547,0.000235383,0.000545995,0.0001168592,0.00007178673,0.00003040645,0.0000663125,0.0001083307,0.002228404],"category_scores_gemma":[0.00004141077,0.0002167961,0.000137086,0.0003278083,0.0001000837,0.0001298909,0.00002843803,0.0002282608,0.000006728349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006459947,"about_ca_system_score_gemma":0.001384451,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007264384,"about_ca_topic_score_gemma":0.007932767,"domain_scores_codex":[0.9983801,0.0000481388,0.0003061727,0.0005375983,0.0002867625,0.0004411949],"domain_scores_gemma":[0.9990536,0.0000877674,0.00009593448,0.0002509513,0.0002586494,0.0002531217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006486182,0.000485692,0.1636459,0.001242069,0.0008968263,0.0003854065,0.002172102,0.0000829882,0.02605492,0.0004952644,0.02571856,0.7723341],"study_design_scores_gemma":[0.04159743,0.0005066358,0.8091786,0.001631019,0.001273846,0.002669929,0.004313122,0.0005022534,0.07106467,0.001302585,0.06451789,0.001442055],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9295213,0.01729766,0.0005681774,0.01896064,0.002510149,0.003118955,0.01127773,0.0001531105,0.01659234],"genre_scores_gemma":[0.9904453,0.001942776,0.001287071,0.001932601,0.0007016078,0.0004619082,0.000077244,0.00006155909,0.003089905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7708921,"threshold_uncertainty_score":0.9993463,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3025373602","doi":"10.1038/s41523-020-0155-1","title":"Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials","year":2020,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Ottawa; Ontario Institute for Cancer Research; Centre for Advancing Health Outcomes; Translational Research in Oncology; University of British Columbia","funders":"Medical Research Council; KWF Kankerbestrijding; National Institute for Health and Care Research; Francis Crick Institute; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Clinical trial; Biomarker; Medicine; Immunotherapy; Workflow; Risk stratification; Oncology; Medical physics; Internal medicine; Computer science; Cancer; Database; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1030303767689564,"gpt":0.4658078125631477,"spread":0.3627774357941914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002291372,0.000282988,0.002860195,0.0001651905,0.00002095303,0.000009316094,0.0001642872,0.0002914856,0.00007436064],"category_scores_gemma":[0.0005755473,0.0002121812,0.001040704,0.0004603125,0.00008892884,0.0000370569,0.00002745475,0.0003240471,0.000001402591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003879266,"about_ca_system_score_gemma":0.0006212572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005076805,"about_ca_topic_score_gemma":0.00005363739,"domain_scores_codex":[0.9961633,0.0003980525,0.002598666,0.0004170662,0.0002539081,0.0001689745],"domain_scores_gemma":[0.995525,0.001303813,0.002649278,0.000339463,0.0001204576,0.00006199652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002106904,0.0001176896,0.0005906543,0.01101229,0.0006558476,0.000001379605,0.00005473712,0.000001020681,0.00001163453,0.0004603149,0.0000791694,0.9849083],"study_design_scores_gemma":[0.01145443,0.0008657034,0.0118418,0.129135,0.009841683,0.00006643066,0.0004222717,0.0008505078,0.0001339252,0.0007614057,0.8338316,0.0007952908],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001118995,0.9824958,0.01223485,0.0000925491,0.0003386337,0.003495631,0.001112368,0.00002125136,0.00009699809],"genre_scores_gemma":[0.001862045,0.9877666,0.008146328,0.00007159451,0.0007148224,0.001229879,0.0001586374,0.00004370599,0.000006441428],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9841131,"threshold_uncertainty_score":0.8652498,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293047601","doi":"10.1038/s41523-022-00458-2","title":"MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Government of Canada; U.S. Department of Health and Human Services","keywords":"Breast cancer; Medicine; Tamoxifen; Body mass index; Breast MRI; Cancer; Poisson regression; Magnetic resonance imaging; Cross-sectional study; Confidence interval; Risk factor; Oncology; Gynecology; Internal medicine; Radiology; Mammography; Population; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01837080790555297,"gpt":0.3159501581145901,"spread":0.2975793502090371,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006742844,0.0005269937,0.0007230384,0.0002815711,0.0005683625,0.0001633136,0.0002179562,0.0001323338,0.009273547],"category_scores_gemma":[0.00001019365,0.0005110253,0.00005486821,0.0005133993,0.0002853201,0.0003964744,0.0005323687,0.0008800356,0.000005998252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003139406,"about_ca_system_score_gemma":0.0007198508,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07562532,"about_ca_topic_score_gemma":0.007318502,"domain_scores_codex":[0.9959204,0.0002499097,0.0006530848,0.001266462,0.001023514,0.0008866092],"domain_scores_gemma":[0.9982615,0.0001434814,0.0003215075,0.0004809865,0.0003142318,0.0004782551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003025379,0.001233316,0.9862401,0.0001286754,0.0004648794,0.00004493168,0.00335711,0.000162165,0.001396418,0.000004977277,0.0004963738,0.003445607],"study_design_scores_gemma":[0.005136712,0.0008792477,0.9898278,0.00008464101,0.0001854444,0.001116406,0.001705489,0.0001035641,0.00006205274,0.00002178083,0.0003830513,0.0004937853],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896896,0.000805811,0.000007592489,0.001227116,0.0007209118,0.001424436,0.005968905,0.00007542551,0.00008018389],"genre_scores_gemma":[0.994826,0.0008689845,0.00002425579,0.0004981849,0.00060346,0.002547478,0.0000698806,0.00007663119,0.0004850939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06830682,"threshold_uncertainty_score":0.9997342,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2254049207","doi":"10.1038/npjbcancer.2015.9","title":"Preventing breast cancer now by acting on what we already know","year":2015,"lang":"en","type":"editorial","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Foundation for Barnes-Jewish Hospital; Breast Cancer Research Foundation","keywords":"Menarche; Breast cancer; Demography; Menopause; Medicine; Incidence (geometry); Quarter (Canadian coin); Cancer; Gynecology; Gerontology; Internal medicine; History","retraction":null,"screen_n_in":null,"score":{"opus":0.01582223323668067,"gpt":0.3270193469797726,"spread":0.3111971137430919,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004996358,0.00110508,0.001605618,0.0002621173,0.0002263982,0.0003609923,0.0004723371,0.001464428,0.003500085],"category_scores_gemma":[0.00009075798,0.0009595754,0.0004687455,0.0004054519,0.0001546953,0.0006459481,0.0001923602,0.002584851,0.0001774023],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00389024,"about_ca_system_score_gemma":0.003440463,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0165491,"about_ca_topic_score_gemma":0.004225641,"domain_scores_codex":[0.9940523,0.0001052314,0.0008041996,0.001478952,0.002319345,0.001240006],"domain_scores_gemma":[0.996054,0.0002831553,0.0008715626,0.0009214248,0.00108738,0.0007825088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009461337,0.0001638117,0.002026987,0.0004499785,0.0003991125,0.00002229421,0.000238902,0.00001011305,0.0001017122,4.624063e-7,0.6813473,0.3142932],"study_design_scores_gemma":[0.003092201,0.000138954,0.001454837,0.01083156,0.0008316536,0.00007519466,0.0003206741,0.00004072721,0.00008486162,0.000007993051,0.9821634,0.000957986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.001832304,0.03141696,0.000006622894,0.006641871,0.9431118,0.001154399,0.01327513,0.0003621451,0.002198801],"genre_scores_gemma":[0.003969807,0.05463608,0.00002069836,0.0004964568,0.915005,0.0005976472,0.001154875,0.0004455489,0.02367393],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.3133352,"threshold_uncertainty_score":0.9999337,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135423629","doi":"10.1038/s41523-021-00226-8","title":"Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Botwinick-Wolfensohn Foundation; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation; U.S. Department of Health and Human Services","keywords":"Breast cancer; Aromatase; Medicine; Internal medicine; Endocrinology; Leptin; Body mass index; Adiponectin; Adipose tissue; Obesity; Cancer; Oncology; Insulin resistance","retraction":null,"screen_n_in":null,"score":{"opus":0.006200436157666598,"gpt":0.250666901086488,"spread":0.2444664649288214,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008940234,0.0001497958,0.0003824213,0.0001049184,0.00004050872,0.0000151289,0.00003557643,0.00006896542,0.0002052967],"category_scores_gemma":[0.0000195759,0.0001035794,0.00002652393,0.0002712283,0.00004326781,0.000119706,0.00002295447,0.000129874,0.000003180852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003712708,"about_ca_system_score_gemma":0.000320818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009060082,"about_ca_topic_score_gemma":0.0005470854,"domain_scores_codex":[0.9989868,0.00005809738,0.0002304609,0.0002755172,0.0002558252,0.000193307],"domain_scores_gemma":[0.9993463,0.00007889171,0.0001253749,0.0002061438,0.0001118176,0.0001314392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01186479,0.0008151773,0.3669624,0.005457407,0.0003385369,0.0006494267,0.005230187,0.000411579,0.4549516,0.00005793939,0.0003688016,0.1528922],"study_design_scores_gemma":[0.004051501,0.0001180461,0.9548486,0.002900534,0.0001096593,0.0008418284,0.0004402757,0.00005847758,0.03637876,0.00001133363,0.0001053858,0.0001355498],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982003,0.0006280834,0.00003905004,0.0003251005,0.00007986537,0.0004038909,0.0002437749,0.00002798872,0.00005194339],"genre_scores_gemma":[0.9991342,0.0002435518,0.0000616594,0.00007762258,0.0001081853,0.0001755419,0.00003220751,0.00001974825,0.0001473146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5878863,"threshold_uncertainty_score":0.4223845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225270990","doi":"10.1038/s41523-022-00425-x","title":"Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Health and Medical Research Council; Cancer Research UK; BC Cancer Agency; QIMR Berghofer Medical Research Institute; Metro North Hospital and Health Service; Department of Foreign Affairs and Trade, Australian Government; Cancer Research Institute","keywords":"SOX10; Biology; Triple-negative breast cancer; Reprogramming; Cancer research; Breast cancer; Phenotype; Neural crest; Genetics; Cancer; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.009202576760837917,"gpt":0.257375750146791,"spread":0.2481731733859531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001608588,0.000211494,0.0002034436,0.00008408187,0.0002145956,0.00002741787,0.0001629445,0.00009882705,0.0004425191],"category_scores_gemma":[0.000009593475,0.0002166516,0.000063707,0.0001864895,0.0000921027,0.000009918483,0.0002413989,0.0002223073,0.000001868009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001435083,"about_ca_system_score_gemma":0.0001638364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003616977,"about_ca_topic_score_gemma":0.002303191,"domain_scores_codex":[0.9985648,0.000141598,0.0002453846,0.0005169561,0.0001937581,0.0003374439],"domain_scores_gemma":[0.9994334,0.00001628107,0.0001281718,0.0002278255,0.00008565935,0.0001086936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0007544112,0.0001382553,0.2562573,0.00003201303,0.00005563692,0.000007521818,0.0004330395,0.004360597,0.7032164,0.00003521779,0.0002813061,0.03442835],"study_design_scores_gemma":[0.001704183,0.0001203947,0.9776729,0.00002198145,0.00003059479,0.00001888204,0.0001849353,0.0006824177,0.01689827,0.0002190291,0.002076874,0.0003694858],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903863,0.006422923,0.00005778367,0.001191812,0.0004133671,0.0003158636,0.001015086,0.00001097717,0.0001858828],"genre_scores_gemma":[0.997116,0.001294636,0.00007028427,0.0003983433,0.0003639676,0.000265574,0.0001000736,0.00003765765,0.0003534868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7214156,"threshold_uncertainty_score":0.8834795,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3193416718","doi":"10.1038/s41523-021-00315-8","title":"Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society Research Institute; Fondation du cancer du sein du Québec; Cancer Research Society","keywords":"Homologous recombination; Proband; Breast cancer; Gene; Homologous chromosome; Genetics; Biology; Recombination; DNA repair; Cancer; Mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.0180938311625258,"gpt":0.2818224295952894,"spread":0.2637285984327636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002472879,0.0003336253,0.0003181709,0.00005522009,0.0001694301,0.00006044703,0.0001852165,0.0003058426,0.0001959855],"category_scores_gemma":[0.00008110829,0.0003446975,0.0003082624,0.000166893,0.00006468804,0.00002014952,0.0001599289,0.0001643541,0.000008385918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003236222,"about_ca_system_score_gemma":0.0004883399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001435336,"about_ca_topic_score_gemma":0.001976336,"domain_scores_codex":[0.9978757,0.000118439,0.0003676653,0.0008380561,0.0002385957,0.0005615402],"domain_scores_gemma":[0.9982485,0.00003474606,0.0002184331,0.0005106731,0.0008340186,0.0001537004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006653409,0.001007824,0.01977708,0.0002002983,0.001046182,0.0002824934,0.0002758687,0.000361521,0.7917653,0.00006677261,0.008801321,0.17575],"study_design_scores_gemma":[0.01175089,0.0005604203,0.1789041,0.0004299256,0.001004107,0.008698968,0.0007096663,0.006898754,0.7239963,0.0004441489,0.06386679,0.002736006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880921,0.003768594,0.000590386,0.0007929502,0.001669203,0.0005554305,0.004353757,0.0001319054,0.00004562996],"genre_scores_gemma":[0.9936518,0.002036003,0.0005999494,0.0005978486,0.000599549,0.0009013025,0.000864694,0.00008673586,0.0006621106],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.173014,"threshold_uncertainty_score":0.9999005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2604847249","doi":"10.1038/s41523-017-0013-y","title":"Breast cancers are rare diseases—and must be treated as such","year":2017,"lang":"en","type":"editorial","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.006888642626517182,"gpt":0.2720832048239323,"spread":0.2651945621974152,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008414477,0.001135768,0.001061311,0.0001124027,0.0006319724,0.0002822733,0.0007142733,0.001260305,0.0002783764],"category_scores_gemma":[0.0001041365,0.001045175,0.0003563681,0.0001001474,0.0006082306,0.00003138897,0.000520013,0.0005383462,0.00002165804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007725465,"about_ca_system_score_gemma":0.001865621,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01386948,"about_ca_topic_score_gemma":0.005815479,"domain_scores_codex":[0.9960631,0.00009773871,0.0004081746,0.001748362,0.0007783909,0.0009042879],"domain_scores_gemma":[0.9966625,0.00006271234,0.0006855361,0.001395781,0.0007220852,0.0004713899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001482546,0.0001058551,0.02428614,0.0002063576,0.001464144,0.00009002646,0.00005671077,0.00000840566,0.0001285535,0.000003097492,0.9631521,0.009016134],"study_design_scores_gemma":[0.003519725,0.0001038129,0.1020951,0.0006748369,0.001181494,0.0002476168,0.0001226572,0.000001714975,0.0001895908,0.00001368075,0.890544,0.001305762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.02085665,0.04856221,0.000007361338,0.005866381,0.7597045,0.001605021,0.1594166,0.0002583263,0.003722948],"genre_scores_gemma":[0.1334094,0.01611349,0.0000155764,0.0004559361,0.8316677,0.001353971,0.006868015,0.0003862595,0.009729751],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.1525486,"threshold_uncertainty_score":0.9991999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3161898366","doi":"10.1038/s41523-021-00264-2","title":"NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital; Montreal General Hospital","funders":"National Cancer Institute; American College of Radiology Imaging Network; Genentech; F. Hoffmann-La Roche; Breast Cancer Research Foundation","keywords":"Medicine; Trastuzumab; Amenorrhea; Gynecology; Breast cancer; Oophorectomy; Internal medicine; Oncology; Triptorelin; Obstetrics; Hysterectomy; Cancer; Hormone; Luteinizing hormone; Pregnancy; Surgery; Gonadotropin-releasing hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.006946025991060778,"gpt":0.2821574875482367,"spread":0.2752114615571759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008897042,0.0001939202,0.0003031644,0.00002686652,0.00003529014,0.000005811894,0.00007766269,0.0001677954,0.0001336685],"category_scores_gemma":[0.000004198464,0.000141586,0.00008649826,0.00006087555,0.0001576882,0.000004667837,0.00003940313,0.0001453065,0.000001232634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002124114,"about_ca_system_score_gemma":0.0008623603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002812785,"about_ca_topic_score_gemma":0.0001045892,"domain_scores_codex":[0.9990587,0.00008347756,0.0001553582,0.0003520909,0.0001322655,0.0002180654],"domain_scores_gemma":[0.9994081,0.000006212654,0.0001049808,0.0002423373,0.0001260929,0.0001123343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002732447,0.0008791029,0.2934146,0.00003814482,0.00162782,0.00005516193,0.0008340171,0.00008024416,0.6296368,0.000005114365,0.002611917,0.0680846],"study_design_scores_gemma":[0.01202887,0.005915162,0.8788448,0.000103378,0.0003698388,0.001490995,0.0007152995,0.00007310246,0.09263751,0.000006043177,0.00717836,0.0006366592],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914497,0.007279262,0.00001813892,0.0000933958,0.0001040918,0.0002045865,0.0000441798,0.00001021699,0.0007964202],"genre_scores_gemma":[0.998639,0.000574657,0.0001196558,0.000105341,0.0001315257,0.00003086668,0.000020034,0.00003245181,0.0003464334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5854302,"threshold_uncertainty_score":0.5773708,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283775775","doi":"10.1038/s41523-022-00442-w","title":"The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"Congressionally Directed Medical Research Programs; Canadian Glycomics Network; Networks of Centres of Excellence of Canada; Michael Smith Health Research BC; Susan G. Komen; Government of Canada; U.S. Department of Defense","keywords":"Polysialic acid; Breast cancer; Cancer research; Cancer; Medicine; Internal medicine; Oncology; Biology; Cell; Neural cell adhesion molecule; Genetics; Cell adhesion","retraction":null,"screen_n_in":null,"score":{"opus":0.007499917206947022,"gpt":0.2558551179403242,"spread":0.2483552007333772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001772716,0.0001268792,0.0001534987,0.00006800341,0.0001256603,0.00002989173,0.0001546865,0.00004042604,0.0001392395],"category_scores_gemma":[0.00001111874,0.00009644821,0.00002831526,0.0001536729,0.0001248487,0.000006649567,0.0002404619,0.0001251098,3.081899e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008660821,"about_ca_system_score_gemma":0.0001600458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001483243,"about_ca_topic_score_gemma":0.001267055,"domain_scores_codex":[0.9988239,0.0001520377,0.0002151578,0.0003235106,0.0002343923,0.0002509493],"domain_scores_gemma":[0.9995893,0.00002202733,0.00008888524,0.0001857633,0.00004887871,0.00006511434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0005490045,0.00006532926,0.120456,0.00004626666,0.00001120789,0.000004371559,0.00008524745,0.0001066933,0.867384,0.00000966793,0.0001440704,0.01113816],"study_design_scores_gemma":[0.001491606,0.0000523858,0.6202901,0.0000763147,0.000007782301,0.00003717056,0.0003956362,0.0004760793,0.3760374,0.00004062394,0.0009276289,0.0001672183],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943454,0.004119373,0.000007945901,0.0006057085,0.0000905997,0.0004286872,0.0003598232,0.000003513186,0.00003895345],"genre_scores_gemma":[0.9977856,0.001167391,0.000009579249,0.00007081498,0.00005444363,0.0006828529,0.00001464702,0.00001490208,0.0001997217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4998342,"threshold_uncertainty_score":0.3933044,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}